txt 20120521 hdrsgml 20120521 20120521163424 accession number 000119312512241844 conformed submission type d public document count filed date 20120521 date change 20120521 subject company company data company conformed name kensey nash corp central index key 0001002811 standard industrial classification surgical medical instrument apparatus 3841 irs number 363316412 state incorporation fiscal year end 1231 filing value form type d sec act 1934 act sec file number 00548201 film number 12859218 business address street 735 pennsylvania drive city exton state zip 19341 business phone 6105947156 mail address street 735 pennsylvania drive city exton state zip 19341 filed by company data company conformed name kensey nash corp central index key 0001002811 standard industrial classification surgical medical instrument apparatus 3841 irs number 363316412 state incorporation fiscal year end 1231 filing value form type d business address street 735 pennsylvania drive city exton state zip 19341 business phone 6105947156 mail address street 735 pennsylvania drive city exton state zip 19341 d ddscdhtm schedule d schedule d table content united state security exchange commission washington dc 20549 schedule d rule d solicitationrecommendation statement section d security exchange act 1934 kensey nash corporation name subject company kensey nash corporation name person filing statement common stock par value 0001 per share title class security 490057106 cusip number class security joseph kaufmann chief executive officer kensey nash corporation 735 pennsylvania drive exton pennsylvania 19341 484 7132100 name address telephone number person authorized receive notice communication behalf person filing statement copy to david shevitz mark wood katten muchin rosenman llp 525 west monroe street suite 1900 chicago illinois 606613693 312 9025200 check box filing relates solely preliminary communication made commencement tender offer table content table content page item subject company information item identity background filing person item past contact transaction negotiation agreement item solicitation recommendation item personsassets retained employed compensated used item interest security subject company item purpose transaction plan proposal item additional information item exhibit annex opinion jefferies company inc table content item subject company information name address name subject company kensey nash corporation delaware corporation kensey nash company address principal executive office company 735 pennsylvania drive exton pennsylvania 19341 companys telephone number 484 7132100 security title class equity security solicitationrecommendation statement schedule d together exhibit annex hereto schedule relates common stock par value 0001 per share company including associated series junior participating preferred stock purchase right the common stock close business may 17 2012 8720449 share common stock issued outstanding item identity background filing person name address company person filing schedule name business address business telephone number company set forth item incorporated herein reference companys website address wwwkenseynashcom information companys website considered part schedule tender offer schedule relates tender offer biomedical acquisition corporation purchaser delaware corporation indirect whollyowned subsidiary koninklijke dsm nv corporation organized netherlands parent dsm disclosed tender offer statement schedule filed dsm purchaser security exchange commission sec may 21 2012 a amended supplemented time time together exhibit thereto schedule to purchase issued outstanding share common stock purchase price 3850 per share net seller cash the offer price upon term subject condition set forth offer purchase dated may 21 2012 a amended supplemented time time offer purchase related letter transmittal the letter transmittal which together offer purchase may amended supplemented time time constitute offer offer purchase letter transmittal mailed together schedule filed exhibit aa ab hereto respectively incorporated herein reference offer made pursuant agreement plan merger dated may 2012 a agreement may amended time time merger agreement among dsm purchaser kensey nash merger agreement provides among thing making offer provides following consummation offer subject satisfaction waiver condition set forth merger agreement accordance delaware general corporation law the dgcl purchaser merge kensey nash the merger kensey nash continue surviving corporation indirect whollyowned subsidiary dsm the surviving corporation effective time merger the effective time share common stock other share held treasury kensey nash owned dsm subsidiary dsm kensey nash held stockholder properly demand perfect appraisal right dgcl tendered pursuant offer cancelled converted right receive amount cash equal offer price the merger consideration copy merger agreement filed exhibit e schedule incorporated schedule reference table content initial expiration time offer 1200 midnight new york city time end monday june 18 2012 subject extension certain circumstance required permitted merger agreement applicable law foregoing summary offer qualified entirety detailed description explanation contained offer purchase letter transmittal copy filed exhibit aa ab hereto respectively set forth schedule to address principal executive office dsm het overloon 6411 heerlen netherlands telephone number 31 0 578 8111 address principal executive office purchaser waterview blvd parsippany 07054 telephone number 973 2578300 item past contact transaction negotiation agreement except set forth incorporated reference schedule date schedule knowledge company agreement arrangement understanding actual potential conflict interest a company affiliate one hand b i companys executive officer director affiliate ii dsm purchaser respective executive officer director affiliate other arrangement kensey nash executive officer director affiliate companys executive officer director affiliate may deemed interest transaction contemplated merger agreement different addition interest companys stockholder generally interest may create potential conflict interest companys board director the board aware interest considered them among matter approving merger agreement transaction contemplated thereby consideration common stock tendered offer companys executive officer director tender share common stock purchase pursuant offer would receive cash consideration term condition stockholder company april 30 2012 companys executive officer director beneficially owned 782995 share common stock aggregate excluding share common stock issuable upon exercise outstanding option connection vesting restricted stock award executive officer director company may deemed beneficially own discussed below companys executive officer director tender share common stock purchase pursuant offer share common stock accepted purchase purchased purchaser companys executive officer director would receive aggregate approximately 30145308 cash share companys knowledge reasonable inquiry companys executive officer director currently intend tender cause tendered share common stock held record beneficially owned other share common stock issuable upon exercise option connection vesting restricted stock award executive officer director may deemed beneficially expiration offer discussed below pursuant offer and necessary vote share favor merger foregoing include share common stock which respect which executive officer director act fiduciary representative capacity subject instruction third party respect tender vote executive officer director company tender share offer upon consummation merger share would represent right receive merger consideration cash term condition stockholder company share common stock beneficially owned generally include share common stock stockholder power vote power transfer includes share common stock table content stockholder right acquire within day however purpose amount described shown table respect companys executive officer director beneficial ownership amount include share common stock stockholder right acquire within day pursuant option purchase common stock either exercisable become exercisable within day vesting settlement restricted stock award vest settled within day effect offer merger equity award incentive compensation plan companys ninth amended restated employee incentive compensation plan the employee incentive compensation plan provides event change control a defined employee incentive compensation plan regardless whether employment termination occurs 1 stock appreciation right sars stock option options granted employee incentive compensation plan including sars option held companys executive officer director outstanding date change control exercisable shall become fully exercisable full extent original award 2 restriction applicable restricted stock award granted employee incentive compensation plan shall lapse award shall become free restriction become fully vested transferable full extent original award 3 performance goal condition respect outstanding performance award cash incentive award shall deemed satisfied full award shall fully distributable extent provided compensation committee board the compensation committee notwithstanding award may fully deductible company section m code purpose employee incentive compensation plan change control occurs if among thing acquisition individual entity group beneficial ownership least fifty percent 50 outstanding share companys common stock combined voting power companys outstanding voting security entitled vote generally election director accordingly change control deemed occur upon acceptance payment of payment purchaser for share common stock pursuant offer the acceptance time purpose employee incentive compensation plan result immediately following acceptance time sars option including held companys executive officer director become fully vested immediately exercisable share common stock underlying restricted stock award including held companys executive officer director become fully vested issued free restriction addition employee incentive compensation plan provides compensation committee may order maintain participants right event change control company 1 make adjustment outstanding award reflect change control 2 cause acquiring surviving entity assume substitute right respect outstanding award additionally compensation committee may cancel outstanding unexercised option sars whether vested exercise price strike price applicable greater fair market value share common stock date change control employee incentive compensation plan compensation committee also ability cash option sars whether vested exercise price strike price applicable le fair market value share companys common stock date change control compensation committee determines award cashed out participant receive per share basis difference exercise price base price applicable lesser fair market value share common stock date change control price paid per share transaction constitutes change control companys fourth amended restated nonemployee directors stock option plan the directors plan provides among thing event change control a defined directors plan option granted directors plan outstanding date change control table content exercisable become fully exercisable directors plan also provides broad authority compensation committee adjust characteristic term outstanding option directors plan reflect effect corporate transaction merger april 30 2012 option purchase aggregate 93000 share common stock issued certain nonexecutive director company pursuant directors plan outstanding fully exercisable companys ability grant option directors plan terminated december 1995 award type granted previously directors plan granted employee incentive compensation plan directors plan provide award sars restricted stock employee incentive compensation plan directors plan filed exhibit e e hereto respectively incorporated herein reference actual consideration paid respect outstanding equity award connection transaction contemplated merger agreement discussed below merger agreement stock option pursuant merger agreement consistent term equity incentive plan company unexercised option purchase share common stock granted equity incentive plan company outstanding immediately prior consummation merger whether vested unvested exercisable unexercisable cancelled effective time exchange cancellation holder option including companys executive officer director entitled receive soon practicable following effective time respect option cash payment le applicable withholding tax equal product a excess merger consideration applicable exercise price per share option multiplied b number share subject option the option cash amount none outstanding option exercise price per share equal greater merger consideration april 30 2012 companys executive officer director held aggregate option purchase 810500 share common stock exercise price ranging 1458 3436 aggregate weighted average exercise price 2693 per share common stock including option acquire share common stock otherwise would exercisable april 30 2012 option purchase aggregate 691072 share common stock held companys executive officer director vested option purchase aggregate 119428 share common stock held companys executive officer unvested outstanding option held companys nonexecutive director vested april 30 2012 described above outstanding option become fully vested immediately exercisable upon acceptance time pursuant term companys equity incentive plan stock appreciation right pursuant merger agreement consistent term equity incentive plan company unexercised sars granted equity incentive plan company outstanding immediately prior consummation merger whether vested unvested exercisable unexercisable cancelled effective time exchange cancellation holder sars including companys executive officer entitled receive soon practicable following effective time respect sar cash payment le applicable withholding tax equal product a excess merger consideration applicable base price sar multiplied b number sars the sar cash amount april 30 2012 companys executive officer held aggregate 180430 cashsettled sars base price 2564 per sar including sars would otherwise exercisable unvested sars ever granted companys nonexecutive director described above outstanding sars become fully vested immediately exercisable upon acceptance time pursuant term companys equity incentive plan restricted stock award pursuant merger agreement consistent term equity incentive plan company upon acceptance time restriction outstanding restricted table content stock award whether vested unvested including restricted stock award held companys executive officer director terminate share common stock issuable pursuant restricted stock award issued subject applicable withholding otherwise free restriction right receive merger consideration effective time to extent share shall tendered accepted payment offer subsequent offering period following acceptance time april 30 2012 companys executive officer director held restricted stock award respect aggregate 42469 share common stock table set forth april 30 2012 subject assumption described below executive officer director company number share common stock beneficially owned executive officer director value share assuming tendered offer accepted purchaser option cash amount represents amount cash executive officer director entitled receive option held executive officer director effective time sar cash amount represents amount cash executive officer entitled receive sars held executive officer effective time value restricted stock award held executive officer director calculated multiplying number share common stock underlying award merger consideration total value common stock beneficially owned by option cash amount option sar cash amount sars value restricted stock award held by executive officer director table content table assumes a merger consummated effective time occurring june 18 2012 b may 17 2012 effective time option sars exercised additional equity award granted c may 17 2012 acceptance time restricted stock award settled share common stock date used quantify interest selected illustrative purpose necessarily reflect date certain event occur name number ofsharesbeneficiallyowned 1 value ofsharesbeneficiallyowned option cashamount sar cashamount value ofrestrictedstockawards total joseph kaufmannpresident chief executive officer secretary 204023 7854886 3238448 933379 12026713 michael celanochief financial officer 6580 253330 803328 259772 96250 1412680 douglas evans pechief operating officer assistant secretary 218080 2 8396080 2556045 722089 11674214 todd dewittvice president biomaterials 17633 678871 375972 128600 1183443 james rauth pevice president operation 1729 66567 431138 147890 645595 john nashvice president new technology 203490 7834365 323212 128600 8286177 walter maupay jrchairman board 65331 2515244 572543 394895 3482682 robert bobbdirector 39410 1517285 538680 320436 2376401 mccollister evarts mddirector 22670 872795 538680 320436 1731911 donald morel jr phddirector 4049 155887 306691 462578 lisa earnhardtdirector 196350 196350 director executive officer a group 782995 30145310 9378046 2320330 1635058 43478744 1 share common stock indicated table beneficially owned include share common stock executive officer director right acquire within day result option either exercisable become exercisable within day share issuable restricted stock award vest settled within day 2 includes 217030 share held douglas evans revocable trust 1050 share held indirectly mr evans minor child employment agreement overview joseph kaufmann chief executive officer douglas evans chief operating officer michael celano chief financial officer todd dewitt vice president biomaterials james rauth table content vice president operation comprising companys named executive officers a defined item 402 sec regulation sk collectively named executive officers employed pursuant employment agreement company such agreement amended andor restated collectively referred executive employment agreements companys executive officer john nash vice president new technology party employment agreement company executive employment agreement provides certain compensation benefit event that following change control a defined applicable executive employment agreement applicable named executive officer terminated company reason cause a defined applicable executive employment agreement executive good reason a defined applicable executive employment agreement either case named executive officers employment term executive employment agreement change control shall occur if individual partnership firm corporation association trust unincorporated organization entity syndicate group deemed person becomes beneficial owner directly indirectly security company representing 50 combined voting power companys outstanding security entitled vote election director company period two consecutive year individual director beginning twoyear period new director whose election nomination election approved vote least three quarter director either director beginning twoyear period whose election nomination previously approved cease reason constitute least majority board substantially asset company liquidated distributed accordingly consummation offer would constitute change control executive employment agreement payment upon termination upon following change control if upon following change control either company terminates executive reason cause executive quits employment company good reason employment term executive executes general release then executive entitled lump sum cash severance payment the severance payment within day following employment termination date equal greatest of amount base salary remaining expiration employment term which messrs kaufmann evans mean june 27 2014 messrs dewitt rauth mean january 2013 mr celano mean march 10 2013 payment equal one estimated bonus a defined applicable executive employment agreement year employment term executive yet received bonus payment would entitled terminated month base salary payment equal one estimated bonus sum of respect messrs kaufmann evans two time base salary two time estimated bonus respect messrs celano dewitt rauth one one half time base salary one one half time estimated bonus executive generally eligible continue healthprescription dental vision insurance coverage month employment termination date becomes gainfully employed eligible benefit new place employment severance payment payment respect medical coverage described represent socalled double trigger payment payable following change control qualifying termination applicable named executive officers employment named executive officers employment table content terminated either company cause executive good reason following change control employment term named executive officer entitled payment base salary accrued employment termination date event executive employment agreement renewed upon expiration original term company obligation agreement named executive officers employment atwill except extent company named executive officer enter new employment agreement defined executive employment agreement cause mean following act fraud embezzlement act dishonesty would reflect adversely integrity company conviction violation criminal statute involving breach fiduciary duty moral turpitude failure executive discharge duty reasonably satisfactory manner failure cured executive within day delivery written notice executive specifying nature failure death executive mental physical disability executive render executive unable effectively perform duty 180 day executives voluntary termination employment result breach companys obligation executives employment agreement good reason mean following change control following material diminution executives base compensation effect date change control material diminution executives responsibility effect date change control relocation executives location employment mile location date change control purpose companys employment agreement messrs kaufmann evans celano term estimated bonus mean amount equal average value cash bonus restricted stock received executive last two full fiscal year executive received cash bonus restricted stock any prior executives termination date purpose companys employment agreement messrs dewitt rauth term estimated bonus mean amount equal average value cash bonus received executive last two full fiscal year executive received cash bonus any prior executives termination date none executive employment agreement provides change control excise tax grossup pursuant executive employment agreement upon change control regardless whether employment termination occurs named executive officers option sars restricted stock award immediately vest named executive officers option sars become remain exercisable full event company terminates executive cause executive quits employment good reason option sar would remain exercisable period one year employment termination date past original term stock option sar table content table set forth april 30 2012 estimated amount would payable companys named executive officer pursuant term respective employment agreement assuming a acceptance time occurs june 18 2012 b named executive officer terminated without cause terminates employment good reason immediately following acceptance time mr nash party employment agreement company entitled severance benefit table assumes bonus paid april 30 2012 date executive officers employment terminated payment exclude amount earned owed executive service rendered date applicable termination salary earned date unreimbursed expense benefit generally available employee company nondiscriminatory basis eg accrued unused paid vacation name benefit change incontrolterminationwo cause orfor good reason joseph kaufmann severance payment 1026063 health care benefit continuation 33200 subtotal kaufmann 1059263 michael celano severance payment 510885 health care benefit continuation 43057 subtotal celano 553942 douglas evans pe severance payment 918936 health care benefit continuation 45586 subtotal evans 964522 todd dewitt severance payment 348426 health care benefit continuation 31863 subtotal dewitt 380289 james rauth pe severance payment 348662 health care benefit continuation 40252 subtotal rauth 388914 1 amount presented determined accordance named executive officers employment agreement assume named executive officer executes delivers general release favor company 2 meaning change control described above 3 event named executive officers employment terminated cause employment term expires due nonrenewal company shall obligation respect named executive officers employment except payment base salary accrued date employment terminates 4 amount calculated using current insurance premium rate january 2012 vesting option sars restricted stock award occur upon acceptance time reflected table immediately above additional information regarding vesting award upon acceptance time see arrangements kensey nash executive officer director affiliateseffects offer merger equity awards above additional information regarding arrangement company named executive officer see item additional informationgolden parachute compensation incorporated item reference table content foregoing summary qualified reference merger agreement filed exhibit e hereto incorporated herein reference employee incentive compensation plan filed exhibit e hereto incorporated herein reference executive employment agreement filed exhibit e e hereto incorporated herein reference rule d safe harbor compensation committee board composed solely nonemployee director independent directors accordance requirement rule dd security exchange act 1934 amended the exchange act instruction thereto approved accordance nonexclusive safe harbor provision contained rule d exchange act among thing payment option cash amount sar cash amount vesting restricted stock award severance payment consideration payable benefit provided companys officer director employee following acceptance time andor effective time connection transaction contemplated merger agreement employment compensation severance employee benefit arrangement within meaning rule dd exchange act section matter accordance requirement merger agreement compensation committee board approved resolution provided disposition common stock including common stock issued pursuant restricted stock award option andor sar pursuant merger agreement including result merger officer director company exempt section b exchange act pursuant rule b thereunder indemnification executive officer director section 145 dgcl provides delaware corporation may indemnify person are threatened made party threatened pending completed action suit proceeding whether civil criminal administrative investigative other action right corporation reason fact person officer director employee agent corporation serving request person officer director employee agent another corporation enterprise indemnity may include expense including attorneys fee judgment fine amount paid settlement actually reasonably incurred person connection action suit proceeding provided person acted good faith manner reasonably believed opposed corporations best interest and respect criminal action proceeding reasonable cause believe conduct illegal delaware corporation also may indemnify person are threatened made party threatened pending completed action suit right corporation reason fact person director officer employee agent corporation serving request corporation director officer employee agent another corporation enterprise indemnity may include expense including attorneys fee actually reasonably incurred person connection defense settlement action suit provided person acted good faith manner reasonably believed opposed corporations best interest except corporation may indemnify person respect claim issue matter person adjudged liable corporation unless appropriate court determines that despite adjudication liability person fairly reasonably entitled indemnity expense court deems proper expense incurred officer director defending action suit proceeding advance final disposition shall paid corporation upon delivery corporation undertaking behalf director officer repay amount advanced shall ultimately determined director officer entitled indemnified corporation officer director successful merit otherwise defense action referred above corporation must indemnify expense officer director actually reasonably incurred table content section b dgcl permit corporation provide certificate incorporation director corporation shall personally liable corporation stockholder monetary damage breach fiduciary duty director except liability 1 transaction director derives improper personal benefit 2 act omission good faith involves intentional misconduct knowing violation law 3 unlawful payment dividend redemption share 4 breach directors duty loyalty corporation stockholder companys second amended restated certificate incorporation the certificate incorporation provides company shall indemnify director may indemnify officer fullest extent permitted dgcl except company shall obligated indemnify person 1 respect proceeding claim action initiated brought voluntarily person way defense 2 amount paid settlement action indemnified company without prior written consent company certificate incorporation also provides company shall advance expense incurred director officer defending proceeding respect may entitled indemnification advance final disposition thereof upon receipt undertaking behalf director officer repay amount ultimately determined entitled indemnification certificate incorporation addition certificate incorporation limit liability director full extent permitted section b dgcl company also entered indemnity agreement messrs kaufmann maupay evans nash bobb each indemnified party agreement require company among thing indemnify indemnified party certain liability may arise reason status service director andor executive officer applicable well advance expense incurred provided undertake repay amount advanced ultimately determined court entitled indemnification indemnity agreement indemnified party also provides following indemnification right limitation addition indemnification certificate incorporation 1 company pay claim within day written notice received company indemnified party may bring suit company recover unpaid amount claim and successful whole part shall also entitled paid expense prosecuting claim 2 company liable claim indemnified party payment made indemnified party insurance policy except respect excess beyond amount payment insurance 3 company liable claim indemnified party based upon attributable indemnified party gaining personal profit advantage brought dishonesty indemnified party provided however indemnified party shall indemnified claim unless judgment final adjudication establishes indemnified party gained personal profit advantage legally entitled committed act active deliberate dishonesty actual dishonest purpose dishonest act material cause action respectively 4 company liable accounting profit made purchase sale indemnified party security company within meaning section b exchange act similar state law description indemnity agreement qualified entirety reference form indemnity agreement filed exhibit e hereto incorporated herein reference pursuant merger agreement dsm purchaser agreed right indemnification currently existing favor present former director officer company subsidiary company employee company subsidiary company act fiduciary companys employee benefit plan each indemnitee provided companys certificate incorporation bylaw pursuant agreement effect may 2012 survive merger remain full force effect merger agreement also provides surviving corporation honor fulfill material respect right indemnification addition dsm purchaser agreed period commencing effective time ending sixth anniversary effective time certificate incorporation bylaw surviving corporation merger contain provision respect indemnification exculpation advancement expense table content least favorable indemnitees provision respect matter set forth certificate incorporation bylaw company date merger agreement merger agreement provides company maintain officers directors liability insurance policy effect may 2012 the do insurance period le six year effective time extent related action omission prior effective time provided surviving corporation may substitute existing do insurance policy least coverage amount aggregate containing term le advantageous former director officer extent substitution result gap lapse coverage respect matter occurring prior effective time event however surviving corporation required expend amount per year equal 300 current annual premium paid company do insurance the maximum amount maintain procure insurance otherwise required merger agreement event annual premium necessary maintain procure insurance coverage described exceed maximum amount surviving corporation required procure maintain sixyear period following effective time much coverage reasonably practicable maximum amount merger agreement also provides that prior effective time company may purchase sixyear tail prepaid policy do insurance satisfy insurance obligation cost per year covered tail policy exceed maximum amount company intends purchase prepaid tail policy permitted merger agreement addition merger agreement provides period commencing effective time ending sixth anniversary effective time surviving corporation shall indemnify hold harmless indemnitee against advance expense indemnitee respect of cost fee expense including reasonable attorneys fee investigation expense judgment fine loss claim damage liability amount paid settlement connection claim proceeding investigation inquiry whether civil criminal administrative investigative extent claim proceeding investigation inquiry arises i action omission alleged action omission indemnitees capacity director officer employee agent company companys subsidiary regardless whether action omission alleged action omission occurred prior to effective time ii transaction contemplated merger agreement provided however if time prior sixth anniversary effective time indemnitee delivers dsm surviving corporation written notice asserting claim indemnification merger agreement claim asserted notice shall survive sixth anniversary effective time time claim fully finally resolved provided further however indemnitee shall enter settlement without prior written consent surviving corporation which consent shall unreasonably withheld delayed conditioned arrangement kensey nash purchaser dsm merger agreement may 2012 company purchaser dsm entered merger agreement summary merger agreement contained section offer purchase description condition offer contained section offer purchase incorporated herein reference summary description purport complete qualified entirety reference merger agreement filed exhibit e schedule hereby incorporated herein reference merger agreement governs contractual right among company dsm purchaser relation offer merger merger agreement filed exhibit schedule provide companys stockholder information regarding term merger agreement intended modify supplement factual disclosure company companys public report filed sec particular merger agreement summary certain term intended be relied upon a disclosure regarding fact circumstance relating company dsm purchaser respective subsidiary affiliate party representation warranty table content covenant contained merger agreement negotiated purpose merger agreement intended solely benefit party thereto many case representation warranty covenant subject limitation agreed upon party qualified certain supplemental disclosure provided party one another connection execution merger agreement furthermore many representation warranty merger agreement result negotiated allocation contractual risk among party and taken isolation necessarily reflect fact company dsm purchaser respective subsidiary affiliate party likewise reference materiality contained representation warranty may correspond concept materiality applicable investor stockholder finally information concerning subject matter representation warranty may change date merger agreement change may fully reflected companys public disclosure appointment director merger agreement provides upon acceptance time time thereafter dsm beneficially owns least majority outstanding share common stock purchaser entitled designate number companys director rounded next whole number equal product total number director board including purchasers designees multiplied percentage number share common stock beneficially owned purchaser dsms subsidiary bear total number outstanding share common stock however effective time purchasers designees elected board board must continue include least two director company officer ie independent director serving director company date merger agreement term merger agreement company agreed promptly take necessary action effect appointment purchasers director designees board including action necessary increase size board obtain resignation current director extent requested purchaser merger agreement also provides that following acceptance time time thereafter purchasers director designees will nearly practicable constitute least percentage committee board board director subsidiary company committee subsidiarys board director purchasers director designees constitute board case extent permitted applicable law rule promulgated nasdaq stock market llc pursuant merger agreement dsm agreed cause individual nominated appointment board upon following acceptance time i furnish company completed director questionnaire respect individuals background qualification ii requested board consent background check iii furnish company background information board andor corporate governance nominating committee board may reasonably request board determines good faith appointment particular designee would constitute breach fiduciary duty companys stockholder merger agreement provides company shall required appoint designee board shall appoint another individual designated appointment board dsm subject individual providing information consent described boards exercise fiduciary duty described above foregoing summary concerning representation board purport complete qualified entirety merger agreement filed exhibit e hereto incorporated herein reference confidentiality standstill agreement connection discussion strategic business opportunity part process led execution merger agreement company dsm entered confidentiality standstill agreement november 14 2011 the confidentiality agreement pursuant confidentiality agreement condition furnished confidential information company dsm agreed among table content thing use confidential information solely purpose evaluating possible transaction company one hand dsm andor subsidiary dsm other dsm also agreed among thing without prior consent company date confidentiality agreement earlier occur execution definitive agreement dsm andor one subsidiary one hand company other regarding transaction such merger agreement november 14 2012 neither dsm affiliate would i acquire security indebtedness other ordinary course business asset company ii make effect commence announce propose tender exchange offer merger business combination involving company iii make way participate solicitation proxy vote seek advise influence person respect voting of voting security company iv form join way participate group within meaning section d exchange act respect voting security company v otherwise seek control influence management board policy company vi advise assist encourage person connection foregoing vii directly indirectly make proposal statement inquiry disclose intention plan arrangement inconsistent foregoing confidentiality agreement remains effect would affected termination merger agreement preceding summary confidentiality agreement purport complete qualified entirety reference confidentiality agreement filed exhibit e hereto incorporated herein reference item solicitation recommendation recommendation board meeting held may 2012 board among thing unanimously determined term offer merger merger agreement fair best interest stockholder company determined advisable best interest company stockholder approve approve merger agreement offer merger transaction contemplated merger agreement authorized execution delivery performance merger agreement transaction contemplated thereby including offer merger authorized grant topup option a defined item statement pursuant merger agreement issuance purchaser share common stock underlying topup option upon exercise topup option payment share common stock issuable upon exercise accordance term merger agreement resolved recommend companys stockholder tender share common stock purchaser pursuant offer and applicable approve adopt merger agreement board unanimously recommends accept offer tender share common stock purchaser offer reason recommendation background board many year conducted periodic regular review strategic position company time time consulted companys management legal financial advisor assist review additionally management regularly meet current potential business partner foster opportunity use development technology also time time investment banking firm including jefferies company inc jefferies ubs bank america citi given presentation companys management andor board regarding acquisition activity companys industry related table content matter presentation jefferies ubs presentation solicited company board firm ubs jefferies retained compensated company result presentation february 2011 response telephone message left joseph kaufmann chief executive officer company christophe dardel president dsm biomedical mr kaufmann conference call mr dardel marc hendriks director global rtd dsm biomedical party introduced agreed meet person learn others business party met person february 21 2011 discussed others business complementary nature technology potential way party might able cooperate respect research development opportunity mr hendriks mr dardel mr kaufmann douglas evans companys chief operating officer attended meeting march 22 2011 mr evans mr hendriks discussed possible application combination dsms material companys technology june 27 2011 company entered mutual confidentiality agreement dsm the cda connection sharing confidential information purpose evaluating potential joint commercial development opportunity possible joint business dealing certain specialized field following execution delivery cda company dsm held meeting discussion sharing limited confidential information specified purpose july 18 2011 company held workshop program attended mr hendriks certain representative dsm workshop company discussed structural degradable polymer component device manufacturing antimicrobial technology certain related technology companys structural biomaterial device experience dsm also provided highlevel comprehensive overview biomedical activity august 18 2011 mr dardel dsms chief innovation officer rob van leen met mr kaufmann mr evans discus potential mutual business arrangement collaboration party mr van leen remarked mr kaufmann dsm might interested acquiring company sale september 2011 company entered discussion privateequity sponsored company operation biomedical field hereafter referred party a respect development execution collaborative product development andor product manufacturing arrangement regularly scheduled meeting board september 20 2011 mr kaufmann provided overview discussion dsm updated board respect recent meeting discussion companys management dsm board encouraged management continue explore business opportunity dsm including possibility strategic transaction company board made decision yet whether pursue strategic opportunity dsm september 26 2011 europe business mr kaufmann met mr van leen eindhoven netherlands mr kaufmann mr van leen discussed need negotiate enter confidentiality agreement purpose exchanging information discussion regarding possible acquisition company dsm shortly thereafter interim confidentiality agreement executed numerous discussion party related potential transaction october 14 2011 special meeting board companys director discussed engagement financial advisor assist discussion dsm potential acquirors board focused jefferies senior banker jefferies financial advisor company many year jefferies previous firm ubs advised company respect number potential market opportunity board approved engagement jefferies provide financial advice assistance table content investment banking service connection possible business combination transaction board discussed possible range value common stock board would hope obtain sale company sale occur board also reviewed draft letter dsm regarding process followed connection due diligence inquiry submitting acquisition proposal company subsequently entered engagement letter jefferies term approved board commenced negotiation confidentiality agreement fulsome agreement standstill nonsolicitation provision binding dsm october 17 2011 direction board jefferies sent aforementioned letter behalf company dsm regarding process followed connection due diligence inquiry submitting acquisition proposal november 2011 mr kaufmann mr van leen telephone conversation pursuant mr van leen asked company deal exclusively dsm respect potential acquisition company based upon direction given board mr kaufmann responded that although company willing listen proposal dsm sale that event company would entertain discussion regarding exclusivity prior receiving proposal connection negotiating confidentiality agreement dsm continued request company deal exclusively dsm regarding potential acquisition company november 14 2011 company dsm entered confidentiality agreement filed exhibit e hereto grant exclusivity dsm november 23 2011 company held twoday meeting several member dsm management team exton pennsylvania following meeting company provided additional document material dsm dsm indicated would deliver nonbinding preliminary offer company based upon companys fiveyear financial plan aforementioned management meeting material presented company meeting company communicated dsm company intend permit due diligence pursue potential acquisition dsm unless dsms preliminary offer range board viewed reasonable special meeting board held november 28 2011 mr kaufmann summarized board impression twoday meeting dsm relayed dsm indicated would provide nonbinding offer next regularly scheduled meeting board held december 2011 representative jefferies discussed board matter related possible transaction dsm discussion included review valuation consideration market metric well overview dsm meeting katten muchin rosenman llp legal counsel company katten led discussion regarding fiduciary duty applicable board connection potential acquisition meeting time time thereafter board discussed effective way obtain highest price per share common stock connection potential acquisition company light risk unintended public disclosure potential adverse consequence associated broad canvassing market board ultimately determined jefferies approach potential private equity strategic acquirors would likely interest acquiring company board engaged active discussion regarding valuation fiduciary duty matter encouraged management continue discussion dsm board instructed management offer company would need range 4000 per share common stock december 2011 st jude medical inc st jude medical companys largest customer informed company that effective november 2011 would pay royalty company respect angioseal vascular closure device the angioseal device reduced royalty rate company disputed reduction asserted claim related royalty payment pursuant license agreement table content company st jude medical certain related matter the dispute royalty payment subject dispute represented substantial portion companys profit december 16 2011 company announced that st jude medicals suggestion agreed enter nonbinding mediation attempt resolve dispute well related claim result dispute december 16 2011 company withdrew earnings guidance quarter ended december 31 2011 two remaining quarter fiscal year 2012 fiscal 2012 whole closing price common stock december 15 2011 2670 following announcement related dispute closing price companys common stock fell 2075 december 16 2011 1851 december 19 2011 december 21 2011 meeting board mr kaufmann relayed board conversation mr van leen pursuant mr van leen indicated dsm would make offer coming day range 2800 2900 per share common stock offer would likely higher valuation dispute concern dsm desired continue due diligence mr kaufmann relayed board informed mr van leen company would interested transaction proposed valuation range consistent previous direction given board board concurred mr kaufmanns statement mr van leen directed mr kaufmann continue adhere position offer company would need range 4000 per share common stock december 22 2011 dsm provided written nonbinding value indication pursuant dsm proposed acquire outstanding share common stock offer range 2600 3000 per share pursuant allcash tender offer followed merger proposal specified proposed transaction would subject financing condition december 28 2011 mr kaufmann jefferies updated board respect proposal dsm discussion board reiterated acceptable proposal would range 4000 per share common stock late december early january mr kaufmann mr van leen continued discus proposed transaction including dsms preliminary offer partys desire move forward due diligence process mr kaufmann expressed dsm offer company would exceed dsm originally proposed and specifically would need range 4000 per share common stock mr kaufmann also expressed dsm proceed unless willing significantly increase offer dsm agreed consider higher offer orally indicated would raise upper end offer range 3500 per share common stock would commit price without diligence special meeting board january 2012 mr kaufmann informed board recent discussion companys management dsm board discussed whether advisable continue process pendency dispute st jude medical board explored potential deal structure mechanism might allow transaction proceed would preserve potential value may accrue company connection successful settlement dispute benefit companys stockholder including contingent value right following thorough discussion legal financial advisor board directed management continue due diligence process dsm january 16 2012 january 20 2012 dsm representative performed due diligence company book record january 20 2012 mr kaufmann representative jefferies met mr dardel michael wahl dsms vice president merger acquisition discus dsms proposal mr dardel stated dsm team intended compile information obtained would make presentation dsms governing body week february 2012 decided following presentation companys scheduled mediation st jude medical two party would conversation february 13 2012 january 24 2012 meeting board mr kaufmann updated board recent meeting company dsm table content february 13 2012 company engaged mediation st jude medical respect dispute executed term sheet respect settlement subject negotiation definitive documentation company informed dsm entered aforementioned term sheet st jude medical dsm expressed desire continue due diligence investigation indicated question regarding companys projection meeting board february 14 2012 board instructed management update year projection reflect term set forth term sheet st jude medical provide projection jefferies dsm potential bidder boards direction beginning early february 2012 jefferies began contacting number company private equity firm determine whether might interested making offer acquire company party private equity company hereafter referred party expressed interest potential acquisition company march 2012 mr kaufmann michael celano chief financial officer company jefferies met mr dardel philip eykerman executive vice president corporate strategy acquisition dsm answer dsms question regarding companys projection followup call mr van leen march 11 2012 mr kaufmann obtained confirmation dsms question regarding companys projection addressed satisfaction dsm mr kaufmann also conveyed dsm public announcement settlement st jude medical would forthcoming mr van leen stated dsm wished wait week following public announcement settlement st jude medical news settlement would time fully absorbed market thereafter dsm would seek approval applicable governing body provide revised offer company march 13 2012 regularly scheduled meeting board discussed development dsm representative jefferies jefferies provided board update effort date pursue potential acquirors board directed jefferies continue effort pursue potential acquirors also directed management jefferies continue dialogue dsm definitive agreement st jude medical executed delivered publicly announced march 16 2012 closing per share price common stock rose 2459 march 16 2012 3020 march 19 2012 following public announcement definitive agreement st jude medical attendant removal uncertainty dispute companys business advance anticipated new offer dsm jefferies intensified effort determine whether party might interested making offer acquire company effort continued throughout march april company engaged discussion dsm course effort addition discussion party party jefferies approached two additional private equity firm well two possible strategic acquirors potential interest transaction company party party reiterated interest potential acquisition company and discussed below took step explore transaction march 26 2012 special meeting board jefferies provided update recent discussion dsm representative jefferies relayed representative dsm indicated dsms management moving proposal acquire company dsms approval process dsm would provide revised proposal company week april 2012 representative jefferies also indicated that discussion dsm jefferies reiterated companys expectation price per share common stock 4000 range march 28 2012 company entered confidentiality standstill agreement party table content march 28 2012 company held teleconference party delivered presentation publiclyavailable material regarding business product customer prospect financial information party agreed review information april 2012 mr kaufmann jefferies met mr van leen mr eykerman mr van leen mr eykerman delivered offer letter stated final proposal pursuant dsm proposed acquire outstanding share common stock price 3550 per share pursuant allcash tender offer followed merger proposed transaction subject financing condition april 2012 special meeting board mr kaufmann described meeting board provided board dsms written proposal also noted dsm stated would expect build north american biomaterials platform around companys operation also explained dsm stated intended retain company management employee create 10 million retention incentive plan encourage achievement business plan fiscal year 2013 beyond detail incentive plan discussed further member company management discussed term continued employment any company merger dsm board discussed jefferies likelihood dsm increasing offer jefferies also informed board party indicated desire learn company potential acquisition target particularly given party as experience biomedical field lengthy discussion board determined company reject dsms offer express dsm company seeking offer 4000 range consistent earlier communication dsm additionally board directed management jefferies continue discussion explore opportunity party party april 2012 boards direction jefferies informed dsm company rejected dsms offer reiterated company seeking offer 4000 range day mr kaufmann mr evans mr celano met representative party mr kaufmann expressed companys expectation price per share common stock acquisition company would range 4000 per share common stock party presented companys fiveyear financial projection april 2012 company entered confidentiality standstill agreement party april 10 2012 mr kaufmann received letter dsm dsm increased offer 3750 per share common stock subsequently april 10 2012 board held special meeting discus letter dsm board discussed proposal dsm length additionally jefferies updated board recent conversation party party jefferies indicated party interested learning company jefferies also conveyed party indicated thought price per share common stock 4000 range higher party willing consider paying party bs calculation indicated valuation mids range board directed mr kaufmann explore mr van leen whether dsm would willing increase offer price higher 3750 per share common stock board also asked jefferies continue discussion regarding potential transaction including discussion party party mr kaufmann two conversation mr van leen following april 10 2012 special meeting board communicated boards desire obtain additional value companys stockholder discussed area companys projection prepared dsm that reconsidered could unlock additional stockholder value mr van leen responded april 11 2012 might able high 3850 per share common stock valuation outside range authorized dsms governing body and consequently additional approval dsms applicable governing body would necessary april 12 2012 special meeting board mr kaufmann relayed content two recent conversation mr van leen jefferies discussed board dsms potential offer 3850 per share common stock jefferies updated board recent conversation party party update jefferies summarized recent effort engage party continued show interest table content potential transaction slow respond jefferies inquiry party continued maintain would comfortable valuation higher mids per share common stock board considered discussed situation variety option board directed mr kaufmann speak mr van leen attempt increase offer dsm possible agreed mr kaufmann able secure increased offer company authorized pursue transaction 3850 per share common stock additional discussion mr van leen became clear mr kaufmann dsms potential offer 3850 per share common stock dsms best final offer april 12 2012 company provided fiveyear projection party april 14 2012 mr van leen informed mr kaufmann dsms governing body approved offer 3850 per share common stock mr kaufmann relayed message board company received draft agreement plan merger april 20 2012 dsm special meeting board held april 24 2012 mr kaufmann updated board status dsm offer including receipt draft agreement plan merger jefferies updated board discussion potential acquirors particular jefferies reviewed board party contacted outcome contact jefferies noted private equity firm contacted expressed interest transaction noted willing proceed valuation exceeded mids board discussed whether would advisable approach additional private equity acquirors effort obtain price per share common stock excess 3850 and based upon feedback private equity firm contacted jefferies insight valuation multiple paid private equity firm concluded effort unlikely result higher offer board discussed selected potential strategic acquirors approached none submitted acquisition proposal well one contacted jefferies relayed board feedback received potential strategic acquirors jefferies discussed whether anticipated potential strategic acquirors would offer price per share common stock excess 3850 board discussed jefferies whether additional potential strategic bidder approached time board consultation jefferies management concluded unlikely approaching additional bidder would result higher offer large part companys attractiveness potential strategic acquirors limited due companys lack sale force potential negative synergy caused competition many company companys industry companys customer board also noted would meaningful opportunity potential bidder serious interest acquiring company emerge public announcement transaction dsm board assistance katten discussed key issue presented initial draft agreement plan merger including transaction would structured twostep transaction consisting tender offer followed merger agreement provided topup option initial draft provide goshop period board discussed length whether goshop period would beneficial stockholder company discussion jefferies katten board believed windowshop provision would sufficient expose company potential bidder especially light effort already made jefferies contact potential acquirors initial draft agreement plan merger also provided i termination fee 45 total equity value transaction payable purchaser connection acceptance alternate proposal certain event ii tender offer would launched promptly practicable following execution delivery agreement plan merger later ten business day following execution delivery agreement plan merger iii purchaser would five business day match competing proposal event one made iv executive officer director company would enter voting tender agreement pursuant person would agree tender share tender offer launched dsm would vote share tendered offer favor merger dsm table content april 24 2012 company announced would release earnings result quarter ended march 31 2012 the earnings announcement may 2012 consistent timing regular earnings release company expected that able conclude negotiation definitive agreement dsm board believed best interest stockholder would announce agreement time earnings announcement rather deliver information market piecemeal fashion company believed best course action given reported earnings would generally line prior guidance well analyst expectation april 25 2012 acting direction board katten sent revised draft agreement plan merger dsms counsel cleary gottlieb steen hamilton llp cleary revised draft agreement plan merger included following provision board directed katten include revised draft i termination fee 30 total equity value transaction ii minimum two calendar week prior launching tender offer allow potential bidder time make offer prior commencement tender offer iii reduction period time given purchaser match competing proposal five business day two business day iv would voting tender agreement april 27 2012 cleary sent revised draft agreement plan merger katten representative katten cleary discussed revision draft agreement plan merger provided among thing i would termination fee 40 total equity value transaction ii dsm purchaser agreed window minimum two calendar week execution delivery agreement plan merger launch tender offer iii purchaser would three business day match competing proposal iv would voting tender agreement additionally april 27 2012 katten sent cleary initial draft disclosure letter april april 30 2012 katten cleary negotiated various term draft agreement plan merger april 29 2012 katten sent cleary revised draft disclosure letter april 30 2012 direction board katten revised agreement plan merger provide termination fee 30 total equity value transaction sent cleary may 2012 dsm agreed companys request companys officer director would subject voting tender agreement cleary also sent revised draft agreement plan merger provided termination fee 375 total equity value transaction may 2012 special meeting board another draft agreement plan merger presented board board consulted katten regarding term condition provided agreement also meeting jefferies reviewed board financial analysis cash consideration 3850 per share common stock discussed opinion companys financial advisor section below determining price paid dsm fair companys stockholder board noted range value implied discounted cash flow analysis presented jefferies reflected range dsms offer price price indicated jefferies analysis board engaged lengthy discussion issue amongst jefferies management discussion board considered significant risk associated companys forecast resulting from among thing revenue profit risk associated loss royalty revenue stream associated angioseal device 2014 substantial uncertainty associated companys early stage product product development pipeline dependence major customer worldwide regulatory economic monetary general industry risk board also authorized management katten accept termination fee 35 total equity value transaction later may 2012 katten called cleary communicate willingness board accept termination fee 35 total equity value transaction cleary later called katten communicate table content dsm agreed reduce request termination fee 35 total equity value transaction cleary sent revised draft agreement plan merger katten disclosure letter also finalized may 2012 katten cleary discussed additional revision draft agreement plan merger cleary sent final draft agreement plan merger katten may 2012 special meeting board close trading day jefferies rendered opinion board effect that date based upon subject various assumption made procedure followed matter considered limitation review undertaken set forth opinion consideration 3850 per share common stock cash received holder share common stock pursuant offer merger fair financial point view holder other dsm purchaser respective affiliate also meeting board unanimously adopted resolution approving agreement plan merger recommending offer merger compensation committee board held meeting approved matter discussed section rule d safe harbor section matter following meeting merger agreement signed prior opening financial market netherlands united state may 2012 company dsm issued press release announcing signing merger agreement reason recommendation special meeting board held may 2012 board approved merger agreement determined recommend transaction contemplated merger agreement including offer merger companys stockholder evaluating offer merger board consulted companys senior management legal financial advisor reaching decision recommend companys stockholder accept offer tender share common stock purchaser pursuant offer approve adopt merger agreement approval adoption merger agreement companys stockholder required applicable law order consummate merger board considered number factor including following offer price board considered fact 3850 price per share paid offer merger represents premium approximately 33 closing price per share common stock may 2012 the day immediately preceding public announcement merger agreement 27 premium week high price common stock period preceding signing merger agreement 53 premium average closing price common stock week period premium volume weighted average price vwap common stock day day period ended april 30 2012 349 430 respectively board also noted offer price exceeded recent price target set number wall street analyst regularly cover company whose report summarized board operating financial condition prospect board considered companys historical projected business financial condition result operation product product development effort management prospect competitive position board evaluated managements strategic plan including financial forecast company remain independent entity assessed inherent risk companys industry business including significant risk associated companys forecast resulting from among thing revenue profit risk associated loss royalty revenue stream associated angioseal device 2014 substantial uncertainty associated companys early stage product product development pipeline dependence major customer worldwide regulatory risk factor set forth companys annual report form k fiscal year ended june 30 2011 risk factor set forth time time companys filing sec including disclosure risk factors filing table content financial market board considered current financial market condition historical market price volatility trading information respect common stock company review strategic alternative board considered potential benefit alternative transaction including alternative transaction structure strategic alliance going private transaction remaining independent company well perceived risk anticipated timing likelihood completing alternative based consideration absence substantial interest potential acquirer acquiring company board believed offer merger favorable companys stockholder strategic alternative reasonably available company including remaining independent company market check board considered result process conducted assistance company management financial advisor pursue acquisition proposal board also considered low probability company private equity firm contacted company financial advisor would ability interest make proposal acquire company higher price offer price reason described caption background well absence meaningful unsolicited offer acquire company companys year history despite well known product position industry board also took account fact none party contacted pursuing transaction offered higher price offered dsm and view board parties proposal lower degree certainty transaction party remained subject extensive due diligence possibly financing addition board believed term merger agreement related companys consideration competing proposal would permit meaningful market check following announcement merger agreement particularly light boards view company well known industry based foregoing process consideration summarized below board believed offer price obtained highest reasonably attainable negotiation dsm board considered belief based upon negotiation dsm resulted multiple increase price per share offered dsm numerous change term condition merger agreement offer price highest price per share dsm willing pay acquire company term merger agreement include favorable term company stockholder dsm willing agree opinion analysis companys financial advisor board considered jefferies financial analysis respect 3850 per share offer price opinion board effect that may 2012 based upon subject various assumption made procedure followed matter considered limitation review undertaken set forth opinion consideration 3850 per share common stock cash received holder common stock pursuant offer merger fair financial point view holder other dsm purchaser respective affiliate fully described caption opinion companys financial advisor assessing discounted cash flow analysis board considered factor discussed operating financial condition prospects bullet point above cash consideration certainty value board considered fact form consideration payable stockholder cash provide stockholder certainty value avoiding longterm business risk term merger agreement board considered term condition merger agreement including limited to ability company prior completion offer consider respond certain circumstance accordance procedure set forth merger agreement unsolicited third party proposal acquire company is would reasonably expected result in superior proposal a defined merger agreement table content ability board i change recommendation favor offer merger andor terminate merger agreement prior acceptance time certain circumstance order enter binding written agreement concerning transaction constitutes superior proposal board determines good faith failure change recommendation andor terminate merger agreement would reasonably likely violate fiduciary duty owed company stockholder ii change recommendation favor offer merger prior acceptance time absence superior proposal material event change circumstance occurred date merger agreement known reasonably foreseeable company prior date merger agreement board determines good faith failure change recommendation would reasonably likely violate fiduciary duty owed company stockholder ability company board make disclosure companys stockholder if good faith judgment board failure would violate boards obligation applicable law including boards duty good faith candor companys stockholder purchasers obligation extend offer beyond initial expiration date offer certain condition consummation offer satisfied waived initial expiration date offer or applicable subsequent expiration date 126 million termination fee payable upon termination merger agreement certain reason set forth therein including accept superior proposal board believed reasonable context breakup fee payable comparable transaction would preclude superior proposal likelihood completion financing condition board considered understanding offer merger would likely completed based absence financing condition fact dsm purchaser represented company financial resource fund offer merger cash hand absence significant regulatory approval necessary complete offer merger could potentially prevent materially delay offer merger require significant effort by resource of party merger agreement board also considered dsms experience completing similar transaction tender offer structure board considered fact transaction would structured tender offer which notwithstanding fact offer would commenced least two week date merger agreement would allow stockholder receive cash offer price pursuant offer relatively short period time would reduce period uncertainty related transaction followed second step merger stockholder tendered share common stock offer exercised appraisal right accordance dgcl receive cash price paid offer possible short form merger board took account fact merger agreement grant purchaser right offer consummated potentially purchase enough authorized unissued common stock topup option a defined item statement effect short form merger acquire remaining equity company pursuant section 253 dgcl without additional approval board topup option may exercised would permit purchaser exercise shortform merger regard board took account fact i minimum tender condition a defined merger agreement offer cannot succeed unless majority companys outstanding common stock on fully diluted basis tendered ii purchaser must acquire least approximately 74 outstanding share common stock offer able exercise topup option effect shortform merger following exercise board also considered fact merger agreement requires company dsm purchaser use reasonable best effort cause merger consummated pursuant section 253 dgcl soon possible following including extent possible day a exercise topup option issuance common stock underlying topup option table content appraisal right board considered availability appraisal right dgcl stockholder tender share common stock offer vote favor merger comply required procedure dgcl including fact stockholder right demand appraisal payment fair value share common stock determined delaware court chancery board also considered number uncertainty risk negative factor deliberation concerning transaction contemplated merger agreement including offer merger negative factor included following effect failure complete transaction board considered possibility transaction contemplated merger agreement including offer merger might materially delayed might consummated adverse effect material delay failure consummate offer merger could companys business market price common stock companys relationship customer employee board considered risk loss key employee disruption normal business relationship substantial distraction management attention transaction pending taxation board considered fact allcash transaction taxable companys stockholder u federal income tax purpose participation future growth earnings board considered fact companys stockholder participate future earnings growth company following merger benefit appreciation value surviving corporation regard board took account possibility price common stock might increased price greater 3850 per share future merger agreement could therefore prevent current stockholder realizing future upside growth discouraging alternative transaction board considered entering merger agreement certain provision contained merger agreement including restriction companys ability solicit competing proposal 126 million termination fee company could required pay certain circumstance may effect discouraging prospective buyer pursuing advantageous transaction company although board view termination fee preclusive competing proposal interim restriction business board considered fact merger agreement restricts companys ability conduct business inasmuch merger agreement requires company obtain purchasers consent engage variety action prior completion transaction contemplated merger agreement interest management board considered fact companys executive officer director may interest transaction different from addition to companys stockholder transaction cost continuing operation board considered significant cost involved connection entering merger agreement completing offer merger related risk disruption operation companys business including risk operation company would disrupted employee concern departure adverse impact ability attract new personnel change termination companys relationship customer supplier andor distributor following announcement offer merger auction board considered fact companys financial advisor required perform auction board concluded that overall potential benefit offer merger companys stockholder outweighed risk uncertainty restriction reason consummate offer merger table content foregoing discussion information factor considered board intended exhaustive light variety factor considered connection evaluation offer merger board find practicable to not quantify otherwise assign relative weight specific factor considered reaching determination recommendation moreover member board applied personal business judgment process may given different weight different factor arriving recommendation board aware interest executive officer director company described item past contact transaction negotiation agreementsagreements kensey nash executive officer director affiliates opinion companys financial advisor company retained jefferies provide financial advisory service connection offer opinion fairness financial point view holder common stock other dsm purchaser respective affiliate consideration received holder connection possible merger sale strategic business combination meeting board held may 2012 jefferies rendered opinion board effect date based upon subject various assumption made procedure followed matter considered limitation review undertaken set forth jefferies opinion consideration 3850 per share common stock cash received holder common stock pursuant offer merger together transactions fair financial point view holder other dsm purchaser respective affiliate full text written opinion jefferies dated may 2012 attached hereto annex schedule opinion set forth among thing assumption made procedure followed matter considered limitation scope review undertaken jefferies rendering opinion company encourages read opinion carefully entirety jefferies opinion directed board address fairness financial point view 3850 per share cash consideration received holder common stock other dsm purchaser respective affiliate pursuant transaction date opinion address aspect offer merger constitute recommendation whether holder common stock tender common stock offer holder common stock vote stockholders meeting held connection merger whether take action respect offer merger summary opinion jefferies set forth qualified entirety reference full text opinion arriving opinion jefferies among thing reviewed draft dated may 2012 merger agreement reviewed certain publicly available financial information company reviewed certain information furnished jefferies companys management including financial forecast analysis relating business operation prospect company held discussion member senior management company concerning matter described prior two bullet point reviewed share trading price history valuation multiple common stock compared certain publicly traded company jefferies deemed relevant compared proposed financial term transaction financial term certain transaction jefferies deemed relevant conducted financial study analysis investigation jefferies deemed appropriate jefferies review analysis rendering opinion jefferies assumed relied upon assume responsibility independently investigate verify accuracy completeness financial information supplied otherwise made available company jefferies table content publicly available including without limitation information described above otherwise reviewed jefferies review jefferies relied assurance management company management aware fact circumstance would make information inaccurate misleading review jefferies obtain independent evaluation appraisal asset liability of jefferies conduct physical inspection property facility of company jefferies furnished evaluation appraisal assume responsibility obtain evaluation appraisal respect financial forecast provided examined jefferies jefferies opinion noted projecting future result company inherently subject uncertainty company informed jefferies however jefferies assumed financial forecast reasonably prepared base reflecting best currently available estimate good faith judgment management company future financial performance company jefferies expressed opinion companys financial forecast assumption made jefferies opinion based economic monetary regulatory market condition existing could evaluated date opinion jefferies expressly disclaimed undertaking obligation advise person change fact matter affecting jefferies opinion jefferies became aware date opinion jefferies made independent investigation legal accounting matter affecting company jefferies assumed correctness respect material jefferies analysis legal accounting advice given company board including without limitation advice legal accounting tax consequence term of transaction contemplated by merger agreement company stockholder addition preparing opinion jefferies take account tax consequence transaction holder common stock rendering opinion jefferies assumed final form merger agreement would substantially similar last draft reviewed it jefferies also assumed course obtaining necessary regulatory third party approval consent release transaction delay limitation restriction condition would imposed would adverse effect company dsm contemplated benefit transaction jefferies opinion use benefit board consideration transaction jefferies opinion address relative merit transaction compared alternative transaction opportunity might available company address underlying business decision company engage transaction term merger agreement document referred therein jefferies opinion constitute recommendation whether holder common stock tender share pursuant offer holder common stock vote merger matter relating thereto addition jefferies asked address opinion address fairness to consideration of holder class security creditor constituency company holder common stock jefferies expressed opinion price common stock trade time jefferies express view opinion fairness financial otherwise amount nature compensation received companys officer director employee class person connection transaction relative consideration received holder common stock jefferies opinion authorized fairness committee jefferies company inc preparing opinion jefferies performed variety financial comparative analysis preparation fairness opinion complex process involving various determination appropriate relevant quantitative qualitative method financial analysis application method particular circumstance and therefore necessarily susceptible partial analysis summary description jefferies belief analysis must considered whole considering portion jefferies analysis factor considered jefferies without considering analysis factor could create misleading incomplete view process underlying conclusion expressed jefferies opinion table content addition jefferies may given various analysis le weight analysis may deemed various assumption le probable assumption range valuation resulting particular analysis described taken jefferies view companys actual value accordingly conclusion reached jefferies based analysis factor taken whole also application jefferies experience judgment performing analysis jefferies made numerous assumption respect industry performance general business economic monetary regulatory market condition matter many beyond companys jefferies control analysis performed jefferies necessarily indicative actual value actual future result may significantly le favorable suggested analysis addition analysis relating per share value common stock purport appraisal reflect price common stock may actually sold analysis performed prepared solely part jefferies analysis fairness financial point view consideration 3850 per share common stock cash received holder common stock other dsm purchaser respective affiliate pursuant transaction provided board connection delivery jefferies opinion following summary material financial comparative analysis performed jefferies connection jefferies delivery opinion presented board meeting may 2012 financial analysis summarized include information presented tabular format order fully understand jefferies financial analysis table must read together text summary table alone constitute complete description financial analysis considering data described without considering full narrative description financial analysis including methodology assumption underlying analysis could create misleading incomplete view jefferies financial analysis transaction overview based upon approximately 94 million share common stock outstanding april 30 2012 noting outstanding stock option would inthemoney assuming vesting inthemoney stock option calculated using treasury stock method restricted stock award cashsettled stock appreciation right or sars jefferies noted consideration 3850 per share common stock implied equity value approximately 3605 million including total debt approximately 289 million net approximately 394 million cash cash equivalent jefferies noted consideration implied enterprise value approximately 3500 million jefferies also noted consideration 3850 per share common stock represented premium 354 closing price per share april 30 2012 2843 premium 350 volume weighted average price per share oneweek period immediately preceding april 30 2012 premium 349 volume weighted average price per share day period immediately preceding april 30 2012 premium 430 volume weighted average price per share day period immediately preceding april 30 2012 premium 534 volume weighted average price per share sixmonth period immediately preceding april 30 2012 premium 507 volume weighted average price per share oneyear period immediately preceding april 30 2012 table content selected public company analysis using publicly available information information provided companys management jefferies analyzed trading multiple company corresponding trading multiple following selected high growth medical technology component supplier company collectively referred selected companies high growth medical technology company nuvasive inc ossur hf resmed inc sirona dental system inc stryker corp william demant holding a component supplier atrion corp gerresheimer greatbatch inc icu medical inc rti biologics inc surmodics inc symmetry medical inc west pharmaceutical service inc analysis jefferies derived compared multiple company and available meaningful jefferies analysis selected company calculated follows enterprise value divided estimated earnings interest tax depreciation amortization ebitda calendar year 2012 referred enterprise valuee ebitda enterprise value divided estimated ebitda calendar year 2013 referred enterprise valuee ebitda price per share divided estimated earnings per share eps calendar year 2012 referred pricee eps price per share divided estimated eps calendar year 2013 referred pricee eps analysis indicated following selected company multiple benchmark high low mean median enterprise valuee ebitda x x x x enterprise valuee ebitda x x x x pricee eps x x x x pricee eps x x x x table content using reference range enterprise valuee ebitda enterprise valuee ebitda set forth companys estimated ebitda calendar year 2012 2013 jefferies determined implied enterprise value company subtracted total debt added cash cash equivalent determine implied equity value using reference range pricee eps pricee eps set forth companys estimated eps calendar year 2012 2013 jefferies determined implied equity value company determining number share common stock outstanding purpose calculating implied value per share jefferies assumed vesting inthemoney stock option calculated using treasury stock method restricted stock award cashsettled sars analysis indicated range implied value per share common stock set forth opposite relevant benchmark below compared case consideration 3850 per share common stock selected company reference range implied price range benchmark referencerange implied pricerange enterprise valuee ebitda x x 3107 3904 enterprise valuee ebitda x x 3425 4443 pricee eps x x 2872 3638 pricee eps x x 3389 4432 company utilized selected public company analysis identical company evaluating selected company jefferies made judgment assumption regard industry performance general business economic market financial condition matter many beyond companys jefferies control mathematical analysis determining mean median meaningful method using selected public company data table content selected transaction analysis using publicly available information information jefferies examined following transaction involving selected company medical technology healthcare sector announced since june 30 2006 transaction considered month date year transaction announced follows date announced acquiror target march 12 2012 asahi kasei corporation zoll medical corporation january 31 2012 angiodynamics inc navilyst medical inc november 17 2011 bain capital llc physiocontrol inc october 2011 getinge atrium medical corporation september 28 2011 johnson johnson sterilmed inc august 25 2011 baxter international inc baxa corporation july 27 2011 becton dickinson company carmel pharma july 20 2011 nordson corporation value plastic inc july 13 2011 apax partner kinetic concept inc june 22 2011 dentsply international inc astra tech june 21 2011 elekta nucletron bv may 16 2011 stryker corporation orthovita inc april 27 2011 johnson johnson synthes inc april 11 2011 endo pharmaceutical holding inc american medical system inc march 31 2011 new mountain capital llc nusil technology llc february 22 2011 gtcr llc sterigenics international inc october 2010 permira llc cregannatactx medical september 2010 company arizant inc august 25 2010 stryker corporation gaymar holding company llc july 15 2010 great hill partner llc sterilmed inc november 30 2009 stryker corporation ascent healthcare solution inc may 2009 covidien plc vnus medical technology inc january 12 2009 abbott medical optic inc advanced medical optic inc july 24 2008 general electric company ge healthcare vital sign inc january 15 2008 warburg pincus llc lifecore biomedical inc november 24 2008 johnson johnson omrix biopharmaceuticals ltd september 15 2008 getinge datascope corporation march 2008 cardinal health inc enturia inc december 20 2007 royal philip electronics respironics inc november 19 2007 olympus corporation gyrus group plc november 2007 getinge boston scientific corporation july 24 2007 teleflex incorporated arrow international inc july 21 2007 ev inc foxhollow technology inc july 15 2007 reable therapeutic inc djo inc may 11 2007 cardinal health inc viasys healthcare inc february 11 2007 cytyc corporation adeza medical corporation december 22 2006 ossur hf gibaud sa december 18 2006 blackstone group lp biomet inc june 30 2006 blackstone group lp reable therapeutic inc using publicly available estimate information transaction jefferies reviewed available meaningful jefferies analysis enterprise value reflected transaction price multiple target companys latest month ltm revenue referred enterprise valueltm revenue ltm ebitda referred enterprise valueltm ebitda table content analysis indicated following selected transaction multiple benchmark high low mean median enterprise valueltm revenue x x x x enterprise valueltm ebitda x x x x using reference range x x companys revenue calendar year 2011 x x companys ebitda calendar year 2011 jefferies determined implied enterprise value company subtracted total debt added cash cash equivalent determine implied equity value assuming vesting inthemoney stock option calculated using treasury stock method restricted stock award cashsettled sars analysis indicated range implied value per share common stock approximately 2853 3765 using enterprise value revenue approximately 3453 4287 using enterprise value ebitda compared case consideration 3850 per share common stock transaction utilized comparison selected transaction analysis identical transaction evaluating transaction jefferies made numerous judgment assumption regard industry performance general business economic market financial condition matter many beyond companys jefferies control mathematical analysis determining mean median meaningful method using selected transaction data discounted cash flow analysis jefferies performed discounted cash flow analysis estimate present value free cash flow company fiscal year ending june 30 2016 using companys managements financial projection discount rate based weighted average cost capital analysis ranging 100 120 and purpose calculating terminal value company end forecast period perpetuity growth rate ranging 40 50 determine implied total equity value company jefferies subtracted total debt added cash cash equivalent implied enterprise value company assuming vesting inthemoney stock option calculated using treasury stock method restricted stock award cashsettled stock appreciation right analysis indicated range implied value per share common stock approximately 4317 6864 compared consideration 3850 per share common stock factor using publicly available information jefferies analyzed premium offered 104 selected healthcare transaction completed pending january 2006 april 20 2012 cash consideration ranging 100 million 500 million transaction jefferies calculated premium represented offer price target companys closing share price one day one week one month prior transactions announcement analysis indicated following premium time period prior announcement premium paid percentage time period prior announcement thpercentile thpercentile median day week month average table content using reference range based th percentile th percentile time period described above jefferies performed premium paid analysis using closing price per share common stock one day one week one month prior april 30 2012 analysis indicated range implied value per share common stock approximately 3481 4828 compared consideration 3850 per share common stock general jefferies opinion one many factor taken consideration board making determination approve transaction considered determinative view board management respect transaction consideration jefferies selected board based jefferies qualification expertise reputation jefferies internationally recognized investment banking advisory firm jefferies part investment banking business regularly engaged valuation business security connection merger acquisition negotiated underwritings competitive bidding secondary distribution listed unlisted security private placement financial restructurings financial service connection jefferies service companys financial advisor company agreed pay jefferies aggregate fee estimated approximately 60 million 500000 payable upon delivery jefferies opinion remainder payable contingent upon consummation offer portion opinion fee contingent conclusion expressed jefferies opinion company also agreed reimburse jefferies reasonable expense including reasonable fee expense legal counsel indemnify jefferies related party certain liability including liability federal security law relating arising engagement jefferies maintains market security company dsm ordinary course business jefferies affiliate may trade hold security company dsm andor respective affiliate account account customer and accordingly may time hold long short position security addition jefferies may seek to future provide financial advisory financing service company dsm entity affiliated company dsm would expect receive compensation projected financial information part strategic planning process boards review strategic alternative companys management prepared fiveyear forecast companys financial performance standalone public company course negotiation relating offer companys management provided fiveyear forecast dsm met dsm discus forecast underlying assumption company also provided jefferies fiveyear forecast use preparing financial analysis risk inherent forecast considered board discussed managements meeting dsm jefferies forecast included following estimate companys future financial performance in million except per share information fiscal year ending june 30 a e e e e e net sale 460 663 766 960 1203 1493 royalty 256 231 254 268 160 202 revenue 716 894 1020 1228 1363 1695 net income 139 148 189 270 299 453 eps 157 168 215 306 340 515 ebitda 285 316 386 510 558 801 table content discussed previous section jefferies presented certain financial analysis board comparative purpose calendar year basis opposed fiscal year basis company analysis assumed i estimated calendar year ebitda 351 million 448 million 2012 2013 respectively ii estimated calendar year eps a defined below 191 261 2012 2013 respectively iii calendar year revenue 803 million 2011 iv calendar year ebitda 294 million 2011 presented nongaap basis described below boards evaluation dsms offer also considered among thing discounted cash flow analysis performed jefferies described caption opinion companys financial advisordiscounted cash flow analysis reflecting jefferies calculation estimated present value unlevered free cash flow based forecast prepared companys management set forth table below in million fiscal year ending june 30 a e e e e e ebitda 285 95 386 510 558 801 depreciation amortization 68 22 82 86 94 104 ebit 217 73 304 424 464 697 tax 350 76 25 106 148 162 244 nopat 141 47 198 276 301 453 depreciation amortization 68 22 82 86 94 104 capital expenditure 23 34 60 100 150 150 increasedecrease working capital 119 05 36 60 11 53 unlevered free cash flow 67 30 184 202 257 354 course preparing forecast company develop estimate unlevered free cash flow unlevered free cash flow calculated jefferies based upon financial forecast provided company set forth ebit le tax plus depreciation amortization le capital expenditure le increase net working capital company deliver estimate unlevered free cash flow dsm potential acqurior presented nongaap basis described below company typically make public forecast future performance earnings limited guidance regarding anticipated quarterly full year revenue net sale royalty earnings per share ebitda specified period companys financial forecast generally prepared solely internal use budgeting management decision forecast set forth included schedule information provided dsm part information considered board evaluating dsm offer forecast also provided companys financial advisor forecast prepared use offer document view public disclosure kind forecast also prepared compliance published guideline sec guideline established american institute certified public accountant regarding projection forecast companys independent registered public accounting firm examined compiled otherwise applied procedure forecast and accordingly assumes responsibility them forecast purport present operation accordance u generally accepted accounting principle gaap ebit ebitda measurement exclude interest tax and case ebitda depreciation amortization expense include estimate stockbased compensation expense additionally net income earnings per share eps ebitda ebit fiscal year ended june 30 2011 exclude acquired inprocess research development iprd pretax charge approximately 182 million incurred connection companys acquisition net asset nerites corporation exclude acquired inventory stepup noncash expense approximately 03 million recorded connection companys acquisition the norian acquisition certain asset certain operational liability comprising product line norian corporation norian estimated net income eps ebitda fiscal year ending june 30 2012 exclude acquired inventory stepup noncash expense approximately table content 10 million recorded connection norian acquisition approximately 06 million legal cost associated settlement discussion st jude medical ebitda ebit unlevered free cash flow fiscal fourth quarter ending june 30 2012 reflect similar adjustment net operating profit tax nopat year ended june 30 2011 estimated nopat unlevered cash flow measurement fiscal fourth quarter ending june 30 2012 reflect similar adjustment and period fiscal year 2013 2016 reflect impact tax based assumed tax rate 35 estimated diluted share outstanding used calculate estimated eps fiscal year 2013 2016 assumes stock option exercise including proceeds exercise stock option stock repurchase change dilutive share due fluctuation stock price forecast reflect numerous estimate assumption made companys management time forecast prepared regarding industry performance general business economic regulatory market financial condition future event well matter specific companys business difficult predict many beyond companys control forecast also reflect subjective judgment made companys management susceptible multiple interpretation periodic revision based actual experience business development accordingly assurance assumption estimate judgment made preparing forecast prove accurate forecast realized addition forecast cover multiple year information nature becomes le predictive successive year inclusion forecast schedule regarded indication company dsm respective affiliate representative considered consider forecast prediction actual future event forecast relied upon such forecast take account circumstance event occurring date prepared including transaction contemplated merger agreement assurance announcement offer transaction contemplated merger agreement cause companys customer delay cancel purchase companys product pending consummation transaction clarification intention respect conduct companys business thereafter delay cancellation customer sale likely adversely affect companys ability achieve result reflected forecast further forecast take account effect failure offer merger occur viewed accurate continuing context none company dsm respective affiliate representative intends update otherwise revise forecast reflect circumstance existing arising date forecast generated reflect occurrence future event even event assumption estimate judgment underlying forecast shown error forecast otherwise become inaccurate companys forecast projection subject substantial risk uncertainty could cause actual result differ materially forecasted result including important factor described heading risk factors companys annual report form k year ended june 30 2011 companys quarterly report form q quarterly period ended march 31 2012 forecast contained schedule forwardlooking statement forwardlooking statement expressly qualified entirety risk described referred item additional informationcautionary note regarding forwardlooking statements companys stockholder cautioned place undue reliance any forecast included schedule intent tender companys knowledge reasonable inquiry companys executive officer director currently intend tender cause tendered share common stock held record beneficially owned respect sole dispositive and applicable voting power table content pursuant offer and necessary vote share favor merger foregoing include share common stock issuable within day upon exercise option vesting restricted stock award executive officer director may deemed beneficially rule sec extent exercise vesting occur prior acceptance time item personsassets retained employed compensated used neither company person acting behalf employed retained compensated currently intends employ retain compensate person make solicitation recommendation stockholder connection offer merger except solicitation recommendation may made director officer employee company service additional compensation paid item interest security subject company please see item solicitation recommendationopinion companys financial advisor summary fee payable jefferies company connection transaction transaction companys common stock effected day prior date schedule company subsidiary company knowledge company executive officer director affiliate company item purpose transaction plan proposal except set forth schedule company undertaking engaged negotiation response offer relate tender offer acquisition companys security company person except set forth schedule company undertaking engaged negotiation response offer relate to would result in i extraordinary transaction merger reorganization liquidation involving company ii purchase sale transfer material amount asset company iii material change present dividend rate policy indebtedness capitalization company pursuant section 68 merger agreement but subject exception unsolicited written takeover proposal board determines good faith would reasonably expected result lead superior proposal defined merger agreement board determines good faith failure take action would reasonably likely violate boards fiduciary duty stockholder company agreed to i solicit initiate knowingly encourage submission of takeover proposal a defined merger agreement ii participate engage discussion negotiation regarding furnish person nonpublic information respect to would reasonably expected lead to takeover proposal iii release third party confidentiality agreement entered connection takeover proposal potential takeover proposal standstill agreement provision company party fail reasonably enforce grant material waiver request consent takeover proposal under agreement except indicated item above transaction resolution board agreement principle signed contract response offer relate would result one matter referred item table content item additional information section f information statement anticipated that requested dsm information statement the information statement furnished companys stockholder connection possible designation dsm pursuant merger agreement person appointed board meeting companys stockholder information statement contain important information regarding companys executive officer director well person appointed board dsm topup option part merger agreement company granted purchaser irrevocable option the topup option purchase number authorized unissued share common stock equal number share common stock that added number share common stock owned dsm purchaser immediately prior exercise topup option constitutes one share 90 number share common stock outstanding giving effect exercise the number topup shares topup option exercisable if immediately prior exercise topup option number topup share exceeds aggregate x number share common stock held treasury share company company subsidiary plus y number share common stock company authorized issue certificate incorporation issued outstanding and reserved issuance pursuant exercise option accordingly purchaser must acquire least approximately 74 outstanding share common stock offer able exercise topup option based number share common stock issued outstanding reserved issuance pursuant exercise option april 30 2012 giving effect issuance common stock underlying restricted stock award outstanding date upon acceptance time and prior exercise topup option exercise price share common stock topup option equal offer price may paid entirely cash paying cash amount equal greater aggregate par value common stock purchased upon exercise topup option executing delivering promissory note company principal amount equal balance aggregate purchase price promissory note full recourse dsm purchaser due one year date topup option share issued bear interest rate per annum may prepaid without premium penalty topup option may exercised time within three business day following later acceptance time and applicable completion subsequent offering period following initial expiration date offer topup option exercised purchaser purchaser required subject term condition merger agreement effect shortform merger dgcl and pursuant merger agreement company dsm purchaser agreed use reasonable best effort cause merger consummated soon possible following including extent possible day a exercise topup option issuance common stock underlying topup option company dsm purchaser agreed appraisal proceeding respect appraisal share a defined merger agreement fullest extent permitted applicable law fair value appraisal share determined accordance section 262 dgcl without regard topup option share issued upon exercise topup option promissory note delivered purchaser company payment share amendment right agreement effective may 2012 prior execution merger agreement board approved company entered into amendment the amendment right agreement dated june 18 2009 the rights agreement company computershare trust company na table content amendment among thing render right agreement inapplicable merger offer merger agreement transaction contemplated thereby amendment amends section a a a right agreement provide neither a announcement commencement consummation offer b execution delivery performance merger agreement consummation transaction contemplated thereby including without limitation offer merger i cause dsm purchaser affiliate dsm purchaser become acquiring person a defined right agreement ii give rise distribution date a defined right agreement iii constitute triggering event a defined right agreement iv trigger certain event specified right agreement amendment also provides right agreement expire immediately prior effective time a defined merger agreement right agreement previously terminated merger agreement terminated change right agreement pursuant amendment force effect foregoing description amendment purport complete qualified entirety full text amendment filed exhibit e hereto incorporated herein reference vote required approve merger section 253 dgcl board approved offer merger merger agreement accordance dgcl section 253 dgcl purchaser acquires pursuant offer otherwise including issuance company share upon exercise purchaser topup option least 90 outstanding share common stock purchaser able effect merger consummation offer without vote companys stockholder shortform merger purchaser acquires pursuant offer otherwise le 90 outstanding share common stock affirmative vote holder majority outstanding share common stock required dgcl effect merger event vote required purchaser hold majority outstanding share common stock would enable purchaser approve merger without affirmative vote stockholder company state takeover law delaware company incorporated law state delaware general section 203 dgcl prevents interested stockholder engaging business combination delaware corporation period three year following date person became interested stockholder unless among thing business combination approved board corporation prior time person becomes interested stockholder interested stockholder acquires least 85 corporations outstanding voting stock transaction became interested stockholder business combination includes among thing merger consolidation involving corporation interested stockholder sale 10 asset corporation general interested stockholder entity person beneficially owning 15 corporations outstanding voting stock entity person controlling controlled common control entity person accordance provision section 203 board approved merger agreement transaction contemplated thereby taken appropriate action restriction business combination set forth section 203 respect company applicable purchaser virtue action without affirmative vote stockholder pennsylvania companys principal executive office located company substantial asset in commonwealth pennsylvania issuer pa target security principal place business substantial asset located pennsylvania whose equity security subject takeover table content offer such transaction contemplated merger agreement subject pennsylvania takeover disclosure law the pa takeover law although section takeover law generally requires offeror file registration statement pennsylvania security commission the pa commission least day prior commencing offer involving equity security target section takeover law provides exemption requirement case target acting board director recommends acceptance stockholder time recommendation first communicated stockholder offeror filed notice the section notice commission notice section takeover law must accompanied fee 100 contain following i information specified section d exchange act ii undertaking notify security holder target notice filed commission contains substantial information offering iii fact necessary establish exemption section takeover law company understands purchaser delivering section notice commission and based companys recommendation set forth schedule section takeover law apply offer merger appraisal right appraisal right available connection offer however merger consummated person stockholder company right section 262 dgcl demand appraisal share common stock right statutory requirement procedure complied with lead judicial determination fair value share common stock purchaser would required pay cash person exercising appraisal right share common stock judicial determination fair value share common stock could based upon consideration than addition to price paid offer merger market value share common stock would exclude element value arising accomplishment expectation merger value determined could le purchase price per share common stock pursuant offer consideration per share common stock paid merger stockholder aware opinion investment banking firm fairness financial point view consideration payable transaction offer merger opinion fair value section 262 dgcl foregoing summary appraisal right section 262 dgcl complete statement procedure followed stockholder desiring exercise appraisal right dgcl preservation exercise appraisal right require strict adherence applicable provision dgcl appraisal right cannot exercised time information set forth informational purpose respect alternative available stockholder merger consummated stockholder entitled appraisal right connection merger receive additional information concerning appraisal right procedure followed connection therewith stockholder take action relating thereto stockholder sell share common stock offer entitled exercise appraisal right antitrust hartscottrodino antitrust improvement act 1976 amended the hsr act related rule regulation issued federal trade commission the ftc certain transaction value specified threshold may consummated specified information documentary material premerger notification report forms furnished ftc antitrust division u department justice the antitrust division certain waiting period requirement satisfied requirement hsr act apply acquisition purchaser share common stock offer merger table content purchase share common stock offer cannot completed expiration calendar day waiting period following filing dsm ultimate parent entity purchaser premerger notification report form concerning offer ftc antitrust division unless waiting period earlier terminated ftc antitrust division dsm plan file premerger notification report form ftc antitrust division connection purchase share common stock offer merger may 21 2012 required waiting period respect offer merger expire 1159 pm new york city time th calendar day date filing occurs unless earlier terminated ftc antitrust division unless ftc antitrust division issue request additional information documentary material second request prior time within calendar day waiting period either ftc antitrust division issue second request waiting period respect offer would extended calendar day following date substantial compliance dsm request unless ftc antitrust division terminated additional waiting period expiration expiration calendar day waiting period waiting period could extended court order consent dsm practice complying second request take significant period time although company also required file premerger notification report form ftc antitrust division connection offer neither companys failure make filing request additional document information issued company ftc antitrust division extend waiting period respect purchase share common stock offer merger hsr act waiting period expired terminated completion merger would require additional filing hsr act purchaser owns 50 outstanding share common stock time merger merger occurs within one year hsr act waiting period applicable offer expired terminated ftc antitrust division consider legality antitrust law dsms proposed acquisition company time purchasers acceptance payment share common stock pursuant offer antitrust division ftc belief offer would violate u federal antitrust law substantially lessening competition line commerce affecting u consumer ftc antitrust division authority challenge transaction seeking federal court order enjoining transaction or share common stock already acquired requiring disposition share common stock divestiture substantial asset dsm purchaser company respective subsidiary affiliate u state attorney general private person also may bring legal action antitrust law seeking similar relief seeking condition completion offer company dsm purchaser believe consummation offer violate antitrust law assurance challenge offer antitrust ground made or challenge made result be action threatened commenced ftc antitrust division state person purchaser may obligated consummate offer merger golden parachute compensation section including table below set forth information required item t sec regulation sk regarding compensation named executive officer based otherwise relates offer merger compensation referred golden parachute compensation applicable sec disclosure rule section term used describe mergerrelated compensation payable named executive officer term merger agreement provide conversion effective time i option outstanding immediately prior effective time including option held named executive officer right receive option cash amount ii sar outstanding immediately prior effective time including sar held named executive officer right receive sar cash amount addition merger agreement provides that immediately following acceptance time restriction outstanding restricted stock award including restricted stock award held table content named executive officer terminated share common stock issuable pursuant restricted stock award issued subject applicable withholding otherwise free restriction right receive merger consideration effective time to extent share previously tendered offer subsequent offering period following acceptance time additional information see item past contact transaction negotiation agreementsarrangements kensey nash executive officer director affiliateseffect merger agreement equity awards incorporated herein reference named executive officer also entitled certain severance payment benefit pursuant executive employment agreement narrative description severance payment benefit amount described table below see item past contact transaction negotiation agreementsarrangements kensey nash executive officer director affiliatesemployment agreements amount set forth table based named executive officers salary estimated bonus may 17 2012 assume following acceptance time effective time occur june 18 2012 named executive officer terminated without cause resigns good reason immediately following acceptance time bonus paid may 17 2012 date named executive officer terminated option sars exercised additional equity award granted may 17 2012 june 18 2012 named executive officer executes delivers general release favor company name cash 1 equity 2 pensionnqdc perquisitesbenefits taxreimbursements other total joseph kaufmann 1026063 1326852 33200 2386115 michael celano 510885 608121 43057 1162063 douglas evans pe 918936 1022032 45586 1986554 todd dewitt 348426 229265 31863 609554 james rauth pe 348662 251527 40252 640441 1 amount column represent double trigger severance payment payable following change control qualifying termination applicable named executive officers employment named executive officers employment agreement company cash severance payment consist of a respect messrs kaufmann evans i 710763 637236 respectively representing amount base salary remaining expiration respective employment term june 27 2014 ii 315300 281700 respectively representing one estimated bonus year respective employment term bonus yet paid b respect messrs celano dewitt rauth i 420810 314676 314162 respectively representing one one half time respective base salary ii 90075 33750 34500 respectively representing one one half time respective estimated bonus 2 amount column represent cash received connection offer merger due accelerated vesting cancellation applicable option sars restricted stock award upon acceptance time effective time applicable consistent companys equity incentive plan amount payable named executive officer pursuant merger agreement regardless whether named executive officer terminated quantification amount set forth column see table appearing item past contact transaction negotiation agreementsarrangements kensey nash executive officer director affiliateseffect merger agreement equity awards incorporated herein reference table content 3 amount column represent double trigger continuation named executive officers healthprescription dental vision insurance coverage month employment termination date becomes gainfully employed eligible benefit new place employment must provided following change control qualifying termination applicable named executive officers employment named executive officers employment agreement company litigation may 2012 putative class action lawsuit commenced company member board dsm purchaser court chancery state delaware lawsuit captioned hilary coyne kensey nash corporation al case no 7508 lawsuit plaintiff alleges generally companys director breached fiduciary duty connection transaction by among thing carrying defective sale process resulted unfair price stockholder merger agreement contains certain onerous preclusive deal protection provision plaintiff alleges dsm purchaser aided abetted board breach fiduciary duty plaintiff purport bring lawsuit behalf public stockholder company seek equitable relief enjoin consummation offer merger rescission offer merger andor rescissory damage fee cost among relief company belief lawsuit without merit may 14 2012 putative class action lawsuit commenced company member board dsm purchaser court chancery state delaware lawsuit captioned david cronin joseph kaufmann al case no 7527 lawsuit plaintiff alleges generally director breached fiduciary duty connection transaction by among thing carrying defective sale process resulted unfair price stockholder merger agreement contains certain onerous preclusive deal protection provision plaintiff alleges dsm purchaser aided abetted board breach fiduciary duty plaintiff purport bring lawsuit behalf public stockholder company seek equitable relief enjoin consummation offer merger rescission offer merger andor rescissory damage fee cost among relief company belief lawsuit without merit may 15 2012 putative class action lawsuit commenced company member board dsm purchaser court chancery state delaware lawsuit captioned louisiana municipal police employees retirement system joseph kaufmann al case no 7534 lawsuit plaintiff alleges generally companys director breached fiduciary duty connection transaction by among thing carrying defective sale process resulted unfair price stockholder merger agreement contains certain onerous preclusive deal protection provision plaintiff alleges dsm purchaser aided abetted board breach fiduciary duty plaintiff purport bring lawsuit behalf stockholder company seek equitable relief enjoin consummation offer merger direct board commence sale process secure best possible consideration company obtain transaction best interest companys stockholder rescission merger agreement imposition constructive trust favor companys stockholder upon benefit improperly received defendant fee cost among relief company belief lawsuit without merit cautionary note regarding forwardlooking statement schedule contains forwardlooking statement defined private security litigation reform act 1995 including statement regarding proposed offer proposed merger expected timing completion offer merger current expectation company prospect opportunity expectation belief plan intention strategy company company tried identify statement using word expect anticipate believe could would should estimate intend may plan predict project forecast guidance projection will similar term phrase word term phrase exclusive mean identifying statement actual result performance achievement could differ materially expressed in implied by forwardlooking statement due table content variety risk uncertainty factor including limited to following uncertainty timing offer merger possibility offer fail meet condition least majority outstanding share common stock fully diluted basis tendered various condition completion offer merger set forth merger agreement may satisfied waived risk governmental entity may prohibit delay refuse grant approval consummation transaction risk dsm perform obligation merger agreement possibility transaction may otherwise delayed may completed all potential negative impact companys business market price common stock companys relationship customer employee could result delay completing failure complete proposed transaction risk loss key employee disruption normal business relationship substantial distraction management attention pendency transaction significant expense potential litigation associated transaction st jude medicals success selling angioseal device extent st jude medical able fact rely internal manufacturing fulfill requirement collagen plug angioseal device excess contractual minimum companys extended collagen supply agreement st jude medical success companys customer partner including arthrex inc stryker corporation synthes inc synthes selling companys related product marketplace companys success research development effort including extracellular matrix cartilage repair adhesive material program companys success uncertainty transitioning norian manufacturing operation companys synthes success distributing norian product success clinical trial u outside u support regulatory approval companys product competition technology well tax risk associated healthcare reform economic condition foreign currency fluctuation detailed discussion factor could affect companys future operating result see companys filing sec including disclosure risk factors filing except expressly required federal security law company undertakes obligation update revise forwardlooking statement whether result new information changed circumstance future event reason table content item exhibit exhibitno description aa offer purchase dated may 21 2012 incorporated reference exhibit aa schedule filed dsm purchaser may 21 2012 ab form letter transmittal incorporated reference exhibit ab schedule filed dsm purchaser may 21 2012 ac form notice guaranteed delivery incorporated reference exhibit ac schedule filed dsm purchaser may 21 2012 ad form letter broker dealer commercial bank trust company nominee incorporated reference exhibit ad schedule filed dsm purchaser may 21 2012 ae form letter client use broker dealer commercial bank trust company nominee incorporated reference exhibit ae schedule filed dsm purchaser may 21 2012 af press release issued company may 2012 incorporated reference exhibit 992 companys current report form k filed company may 2012 a letter stockholder chief executive officer company chairman board director company dated may 21 2012 aa opinion jefferies company inc board director kensey nash corporation dated may 2012 incorporated reference annex attached schedule d ab form summary advertisement published may 21 2012 wall street journal incorporated reference exhibit af schedule filed dsm purchaser may 21 2012 ac transcript conference call held company may 2012 800 am eastern daylight time incorporated reference companys schedule dc filed sec may 2012 e agreement plan merger dated may 2012 among dsm purchaser company incorporated reference exhibit 21 companys current report form k filed may 2012 e mutual confidentiality standstill agreement dated november 14 2011 company dsm incorporated reference exhibit d schedule filed dsm purchaser may 21 2012 e amended restated employment agreement dated january 2009 company joseph kaufmann incorporated reference exhibit 101 companys current report form k filed sec january 2009 e amended restated employment agreement dated january 2009 company douglas evans pe incorporated reference exhibit 102 companys current report form k filed sec january 2009 e amended restated employment agreement dated january 2009 company todd dewitt incorporated reference exhibit 102 companys quarterly report form q quarterly period ended december 31 2008 table content exhibitno description e amended restated employment agreement dated january 2009 company james rauth pe incorporated reference exhibit 104 companys quarterly report form q quarterly period ended december 31 2008 e employment agreement dated march 10 2011 company michael celano incorporated reference exhibit 101 companys current report form k filed sec march 15 2011 e mutual consent extend employment term dated march 16 2010 company joseph kaufmann incorporated reference exhibit 101 companys current report form k filed sec march 22 2010 e mutual consent extend employment term dated march 16 2010 company douglas evans pe incorporated reference exhibit 102 companys current report form k filed sec march 22 2010 e mutual consent extend employment term dated october 15 2010 company todd dewitt incorporated reference exhibit 101 companys current report form k filed sec october 21 2010 e mutual consent extend employment term dated october 15 2010 company james rauth pe incorporated reference exhibit 102 companys current report form k filed sec october 21 2010 e waiver amendment employment agreement dated july 18 2011 company joseph kaufmann incorporated reference exhibit 101 companys current report form k filed sec july 22 2011 e waiver amendment employment agreement dated july 18 2011 company douglas evans pe incorporated reference exhibit 102 companys current report form k filed sec july 22 2011 e waiver amendment employment agreement dated july 18 2011 company todd dewitt incorporated reference exhibit 103 companys current report form k filed sec july 22 2011 e waiver amendment employment agreement dated july 18 2011 company james rauth pe incorporated reference exhibit 104 companys current report form k filed sec july 22 2011 e amendment amended restated employment agreement joseph kaufmann president chief executive officer dated october 21 2011 incorporated reference exhibit 101 companys current report form k filed sec october 26 2011 e amendment amended restated employment agreement dated october 21 2011 company douglas evans pe incorporated reference exhibit 102 companys current report form k filed sec october 26 2011 e amendment amended restated employment agreement dated october 21 2011 company michael celano incorporated reference exhibit 103 companys current report form k filed sec october 26 2011 e amendment amended restated employment agreement dated october 21 2011 company todd dewitt incorporated reference exhibit 104 companys current report form k filed sec october 26 2011 table content exhibitno description e amendment amended restated employment agreement dated october 21 2011 company james rauth pe incorporated reference exhibit 105 companys current report form k filed sec october 26 2011 e mutual consent extend employment term dated october 21 2011 company joseph kaufmann incorporated reference exhibit 106 companys current report form k filed sec october 26 2011 e mutual consent extend employment term dated october 21 2011 company douglas evans pe incorporated reference exhibit 107 companys current report form k filed sec october 26 2011 e mutual consent extend employment term dated october 21 2011 company todd dewitt incorporated reference exhibit 108 companys current report form k filed sec october 26 2011 e mutual consent extend employment term dated october 21 2011 company james rauth pe incorporated reference exhibit 109 companys current report form k filed sec october 26 2011 e ninth amended restated company employee incentive compensation plan incorporated reference exhibit 101 companys current report form k filed sec december 13 2011 e form directors indemnity agreement incorporated reference companys registration statement form s registration no 3398722 e company fourth amended restated nonemployee directors stock option plan incorporated reference exhibit 45 registration statement form s registration no 33371050 e amendment dated may 2012 right agreement dated june 18 2009 company computershare trust company na incorporated reference exhibit 41 companys current report form k filed sec may 2012 e second amended restated certificate incorporation company incorporated reference exhibit 31 companys registration statement form s registration no 3398722 annex iopinion jefferies company inc table content signature due inquiry best knowledge belief certify information set forth statement true complete correct kensey nash corporation date may 21 2012 by s joseph kaufmann name joseph kaufmann title president chief executive officer secretary table content annex jefferies company inc 520 madison avenue new york 10022 tel 2122842300 jefferiescom may 2012 board director kensey nash corporation 735 pennsylvania drive exton pennsylvania 19341 member board understand kensey nash corporation the company koninklijke dsm nv parent biomedical acquisition corporation whollyowned subsidiary parent merger sub propose enter agreement plan merger the merger agreement pursuant i merger sub would commence tender offer the tender offer purchase issued outstanding share common stock par value 0001 per share company common stock price 3850 per share the consideration ii following consummation tender offer merger sub would merge company company surviving merger wholly owned subsidiary parent the merger pursuant term merger agreement share common stock tendered accepted pursuant tender offer other share common stock held treasury company owned merger sub parent whollyowned subsidiary parent company share canceled dissenter right properly exercised would converted right receive consideration tender offer merger taken together referred transaction term condition transaction fully set forth merger agreement asked opinion whether consideration received holder share common stock pursuant transaction fair financial point view holder other parent merger sub respective affiliate arriving opinion have among thing i reviewed draft dated may 2012 merger agreement ii reviewed certain publicly available financial information company iii reviewed certain information furnished companys management including financial forecast analysis relating business operation prospect company iv held discussion member senior management company concerning matter described clause ii iii above i table content v reviewed share trading price history valuation multiple common stock compared certain publicly traded company deemed relevant vi compared proposed financial term transaction financial term certain transaction deemed relevant vii conducted financial study analysis investigation deemed appropriate review analysis rendering opinion assumed relied upon assumed responsibility independently investigate verify accuracy completeness financial information supplied otherwise made available company publicly available including without limitation information described above otherwise reviewed u relied assurance management company aware fact circumstance would make information inaccurate misleading review obtain independent evaluation appraisal asset liability of conduct physical inspection property facility of company furnished evaluation appraisal assume responsibility obtain evaluation appraisal respect financial forecast provided examined u note projecting future result company inherently subject uncertainty company informed u however assumed financial forecast reasonably prepared base reflecting best currently available estimate good faith judgment management company future financial performance company express opinion companys financial forecast assumption made opinion based economic monetary regulatory market condition existing evaluated date hereof expressly disclaim undertaking obligation advise person change fact matter affecting opinion become aware date hereof made independent investigation legal accounting matter affecting company assumed correctness respect material analysis legal accounting advice given company board director including without limitation advice legal accounting tax consequence term of transaction contemplated by merger agreement company stockholder addition preparing opinion taken account tax consequence transaction holder common stock assumed final form merger agreement substantially similar last draft reviewed u also assumed course obtaining necessary regulatory third party approval consent release transaction delay limitation restriction condition imposed would adverse effect company parent contemplated benefit transaction i table content understood opinion use benefit board director company consideration transaction opinion address relative merit transaction contemplated merger agreement compared alternative transaction opportunity might available company address underlying business decision company engage transaction term merger agreement document referred therein opinion constitute recommendation whether holder share common stock tender share pursuant tender offer holder share common stock vote merger matter related thereto addition asked address opinion address fairness to consideration of holder class security creditor constituency company holder share common stock express opinion price share common stock trade time furthermore express view opinion fairness financial otherwise amount nature compensation payable received companys officer director employee class person connection transaction relative consideration received holder share common stock opinion authorized fairness committee jefferies company inc engaged company act financial advisor company connection merger receive fee service portion payable upon delivery opinion significant portion payable contingent upon consummation transaction also reimbursed expense incurred company agreed indemnify liability arising connection service rendered rendered engagement maintain market security company parent ordinary course business affiliate may trade hold security company parent andor respective affiliate account account customer and accordingly may time hold long short position security addition may seek to future provide financial advisory financing service company parent entity affiliated company parent would expect receive compensation except otherwise expressly provided engagement letter company opinion may used referred company quoted disclosed person manner without prior written consent based upon subject foregoing opinion that date hereof consideration received holder share common stock pursuant transaction fair financial point view holder other parent merger sub respective affiliate truly yours s jefferies company inc jefferies company inc i exa ddexahtm letter stockholder letter stockholder exhibit a may 21 2012 dear stockholder publicly announced may 2012 kensey nash corporation kensey nash entered agreement plan merger dated may 2012 the merger agreement koninklijke dsm nv dsm indirect whollyowned subsidiary biomedical acquisition corporation provides acquisition kensey nash dsm pleased report that pursuant merger agreement biomedical acquisition corporation today commenced tender offer purchase outstanding share kensey nash common stock including associated series junior preferred stock purchase right 3850 per share common stock cash tender offer conditioned upon among thing least majority kensey nashs outstanding share common stock fullydiluted basis tendered expiration termination waiting period applicable antitrust law united state customary condition tender offer scheduled expire 1200 midnight new york city time end monday june 18 2012 subject extension required permitted merger agreement security exchange commission applicable law following consummation tender offer successful subject term condition set forth merger agreement biomedical acquisition corporation merge kensey nash kensey nash become whollyowned subsidiary dsm merger share kensey nash common stock remain outstanding following consummation tender offer other share held person properly exercise appraisal right converted right receive 3850 per share cash set forth enclosed solicitationrecommendation statement schedule d kensey nashs board director unanimously determined tender offer merger fair best interest kensey nash stockholder also approved declared advisable merger agreement transaction contemplated thereby including tender offer merger accordingly board director kensey nash recommends tender share pursuant tender offer addition solicitationrecommendation statement schedule d accompanies letter also enclosed biomedical acquisition corporations offer purchase related material including letter transmittal use tendering share urge read enclosed schedule d offer purchase material carefully we well member board director management kensey nash thank support given kensey nash throughout year sincerely s walter maupay jr walter maupay jr chairman board s joseph kaufmann joseph kaufmann president chief executive officer secretary graphic ggajpg graphic begin 644 ggajpg mcxdaospnxdet mcat mxxdedx mdeqhufqf mffh mtxp mph mz matxdex mmfq mpqa mxde matxdepwt mxvcxdof mladlqppqqqpp mppppppppptptax mxppppppppppp mpspaqtp mphp mlppagdqbd mctekpu mxydaqduqefhikunvtwezwqgq mpuaadalcpd mnriqcrlxtwct miteyemygejvqmfbih mqpuwyloltgwlygkvsztjez muohsthoemykscowlzvhftrwgxdv mzgbxfvloqzumlvrasewvstesddixnon mxpahgnwxhhroxkjczqcovcbucuzo mimauvlzcoivhwgttwxddizqnfkojlrmmuif mvfoqvmltmvahdudh mtgfjdeuzuohsthezuothoemmw mlopopqokpjtdevxde mdehooo mopsppnat mpxddve mpp mpppppppppp mppppppppap mp mppdf muabrsasemsaxby mhqpw mkxrrfrfxxagldcxqgphevxzfezslt mjhbcdebldhnomxmkf mfpydpxixuavqtlhiwpwzvm mupfptxsqdmijtnywrx mmoqrnoyxtpxpdmxnuqhk mhirrpssqqqqtaqtorrmcozfik mqgwhgnbitcoonwtzkwwaiwhcgxjv mhlggnbitcoonwtzkwwaiwhc mbhudptmtmqrmxvzvgghrkbksc mcirpdigoctxtfzpkkuyxznfku mwbncgunvkglplkwcrngrhomw mpuewsqplggvjmfmaqolflwmhqnsa mgtxqssqsqqckwwaiwhcbhud mptmtmqrmxvzvgochzyqakbnli manvhcpjliiekwhzxxznqytwsrqspp mlggnbitviylyapmtvcccbpdjybgdvyzdwrvilgjxtgupbta mfhjbw mkugijfvodsf mezgmuvufuppluesqlbexv mdagpaxtwzpvdznehyvfoty mpchixohobbncljbihsidgyuvsz mkwbxmnklcsoanvpjxqbibwaqp mvckbefoeqljydhcxrfnzelm mrgppfmzzocgzqrxnxidu mmeqapayvdnykkrfjbjxdsqavqcbrdpdatsnankdfbe mzlhgjivgpgljakwoi mswmlfeqcufkrgrdeciroesbfwdwu mnllmldkzqhvwzlnkbcqjbxrhgd mzgbzefdlxsrlfipethoyzwvvaahsz myffjhbqskwvfkscyqwts myuonxcepcd mrscxwadwjyvjiezjtejirjhhwc mktydrbaaufcdp myipzhnruadnyeshynqunnu mmarmbigsrqrmwjdvkwpvdjvas mtvemjilelxcvavazdekfgjzmp mxpifrhepemhuxmomwwthnfwxkwdprm mhqcumuiyxahbptlospeeo mourphpgqvewtonoeqtgflbm mvwudr mzqqkiqkuuiahne muxzzartjksngvogdnzifcpoantebdzrb mkhzbilxdpopjocnqumknkpwlrdgrcodicca mbgjvqcorpbjjhftgvwfwqfqu mikpmynfzqdfcbdzvpevdntbbbw mpeqtulgoqjgsdecddirjyboomatbfa mfcwyccfvywudjloekjdgtaydtrhdrkuocnldximz mjcrrdjxgbxqxtpebxupipx mvfaogmgafzqggzze mgihndmmigstmgfddaxfhveaab mqdlbqxuebtvicqlvpoektlcfloorzsg mnwrhxvpnbakafvgccbbfzom mpmpgfscheeemsrtkmfbudmp mfglcjhhrphhwssmlosjnvbif mlgnznkuosukwqy mdpibiqrrsucghxhjdxs mbnaefqambdsd mbvxphwuwhhhhhhhhhhhh mhtbpphmwslsufyertwgydwaoz mxtscammspujlpzytooaocgk maofotizvpweajhlzln mwguxqnjpwppnwguxfzpunenyouujdchqqyauo mxwleqniavmdnwupkwayhleqniavm mdnwupkwayhleqniavmrxtechab mcbmjlfgoxgicwzwwlonsspthjbg mvwwnyxuqlwpinowfguqlw minowfgaiwwlonsspthjbgvwwnyxp mqtpcfsflekimzrxsasdmefuvsrcfiuc mjprdgcccuphwlbwezoufio megsteewbmbrhsbgrcqogqyqsomxksxlj mxfwvdlhkyufioevb mryebcseidhvyevqugtsucgu mozfmufioegsteewbmbr mhsbgrcqogqyqsomxksxljxfwvdlhky mufioegsteewbmbrhregxy mqcznwtyrrsqchedsejyxlmqb mrsfrtrgbpnamcndisroqzcwfeag mglhjuwyzrejdeplxgyaimxrm mqqbvpraromqkkacruo muzfxigvnaiwwlonsspzfxigvne msnwinowfgaiwwlonsspthjbgvwwny mxuqlwpinowfguqlw minowfgaiwwlonsspthjbgvwwnyxuq mlwzfxigvneuknrbgfwabxpexwjw mmggkeeeqqtojwxoscv mlxojwxoscvlxojwxos mcvlxojwxoscvlxoj wxoszqrxtv end text document document typegraphic sequence filenameggbjpg descriptiongraphic text begin 644 ggbjpg mcxdiaospnxdet mcat mxxdedx mdeqhufqf mffh mtxp mph mz matxdex mmq msw mxde matxdepz mxlcxdof mladlqppqqqpp mppppppppptptax mxppppppppppp mpspaqtp mphp mlppagdqbd mcthpedepxcshkdpjtaekpu mxydaqduqefhikunvtwezwqgq mpuaadalcpd mnriqcsqhkrupmducvtrlxtwct miteyemygejvqmfbwugxih mqputkuucczinojuwigulvmu mzhbqsutnvnemmqwojytrocaugbtoho mkblygexsrlrbcmvxnqnvkroznygzsz mpjyymkwklvbtkzkpjgioblykze msmuxklnvskubgicbnkqixzjzra monlmtkugfqeiczliwunkzjugduwdmll mwkzuhplxmjpzstjfenvftuunvup mhctsfedguvgzgtrczbflze mwlmhzhvostuibwlsjrgzvkfutvmg mugrczytzntheqakywzuqthvwjq mcwulwqnakqiekgwkkerguzh mdxojzwsnpkzugzlynubkqzzniwm mlzfyelnpjykvqgttxufkcno mnmnfhwieeszntdrulfsgwnvldiwjybqfsv mijwuxgnzewthsjmguslunrmlwviwt mmkswkfbztmilsgtzgnyspqqofwh mqdcjpuwfnmswoyfygekddirspfqozm mkqhgyzilwuzkgiydymafpilczm mjwufueftnzfuattupusefmgkwzoop miikszsllvohlracchreyew mpbbsznovgmjgjsgyuzsfkwkwkef mzvazbexvddikoupztwdxucvsgngjo mjnzzuuzkziuivuipzidklqeewzyw msjzosdddiopeldpnwpojllv mvgwytxnddihmgzxunkexwlwni mbqzujlvhupkqugjvczbpkdtxemkjg mkdsagvamgcolvvimhkshkqamzhsg mtuhshhxocszyuohiwkrq mcompejzaaaomztyntluvaqe mxodeougztzorcgvunhpsqmtugzo miuwzjojitzzkjyqtwtkovl mlzodedao mopsppppbpt mphpxdeny mbdvp mppp mppppppppppppp mpppdpwq mpdpq mhkymacawsaxbha mslwuhpreqh mqpquvfysutitozczizrjvmnoid mwhsqgicpxikrgfjfqcan muiknvvdiqngfjllxcacqqodnsyjxzb mffnjaheohqsiauvqdeezsvwctfankdk memktleipzfigkdylxljuascsbsxrsjluki mjyjqjcuutwknptzhjjgfnurrhbbhf mrsgsduhioherxzgutvul mclrlescmdadqhsizobybzxkucv mlvybbblrgsebliqedbijsbgsq mhaqcnviggsrlozyasgeafoveozffo mfendyrhduiaixcnispjdf mtjfduusuqncwjfamejpy mxcjcosrczyfhpmglbq mlzjhjzomkwegodsmdzmfvgjaxdklvu mtzdeflgpmobqjuafrwmstfx mamlmhdnuzolresidyqeduh mhbpashqxlwtpndqtnbcbirmp mrzuiejlsdhcrxlchdfxzijuwkkjiwpb mskivalqmegfqbixdqtlrx mwgkmnrshlbyflyq mwbqcsczlzocqeoolkrvuzvcryeqo mpnykrqfkwsitinljqlejxbwjv mdewxgnnhkkxdkxblpkqp miehhtjmgyhicmtyegceisfk miomdbfzkevgnihvqdlabvehnd mdmiiqaoqmnpfuenlrqlymoc megmpyfwgvnbpsvigawtanjvc mapwjkcmiaaskrhdyvfdlfumibfn mtbolshmlbdipnlplfgcidqrrveq mpffxdhtqhcmaiigihrxpenoehbjxj meffglugyltqlfrdhwncoautv mukksfmsmsgeedbberubnsgjne mjltdqspcrcitetzndouwnblbaom mjfonfjnbpagokddmmfktqpaf mhkxccbfmyfcosqlkhpqo maweomnlvredusldtheeijpynhv mvmapvuspvufgfazfcebrhapcrcp msdjncgaglvbnpm msgbqlvygaqaadirfnchvoxsixvuj mramtjrszyxovjmiddassm mdwezilnvsiutjqkwfruosl mqfqaecxbmwyvxetznzpvpmemrjdtc mxgkvhqpeivhmjyfhadjqfmrxikn mmexxvksgcoaceqapsfizsqatot mjvvpfevatqphedefembzzuvsnc mtxnzqdvpiegdlugfukruudqnjfkv mdyrrtjzchynapekcbobdc mpmvyledxvitoalenrfafzkecstj mixjvjnqrcqcpjvvmrvqugvvngmfsig mtagdifcshpqlidyjfuclrxsd mtzrijkkzegcitetznbonajmx mfpwikmdguxlqllfbkyvneuvtri mxajbmupglowjxvhbvfmjylqiitkm mkdtsxadzjrislmcwaaedancvbyr mhtymwfulprqlkmdgjnrqhdskhrld meaigybifscrgtkxywifefxzkvhs mjdzioujokqwgxtwogg mkvlnmrkykonkefrkubsow msypjhregxgmxjzfhlicnw mfrkgvskauzloqwmokjonpyenk mzgkrgpovktbhgwyvhgthtj medosipctigksucjwomlmri xoeqgvbsaqmzjd end text document secdocument